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Abstract 
Noninvasive imaging of cardiac electrical activity is of great importance and can 
facilitate basic cardiovascular research and clinical diagnosis and management of various 
malignant cardiac arrhythmias. This dissertation research is aimed to investigate a novel 
physical-model-based 3-dimensional cardiac electrical imaging (3DCEI) approach. The 
3DCEI approach is developed by mathematically combining high-density body surface 
electrocardiograms (ECGs) with the anatomical information. Computer simulation study 
and animal experiments were conducted to rigorously evaluate the performance of 
3DCEI. The simulation results demonstrate that 3DCEI can localize the origin of 
activation and image the activation sequence throughout the three-dimensional 
ventricular myocardium.  The performance of 3DCEI was also experimentally and 
rigorously evaluated through well-controlled animal validation studies in both the small 
animal model (rabbit) and large animal model (canine), with the aid of simultaneous 
intramural recordings from intra-cardiac mapping using plunge-needle electrodes inserted 
in the ventricular myocardium. The clinical relevance of 3DCEI was further 
demonstrated by investigating 3DCEI in cardiac arrhythmias from animal models with 
experimentally-induced cardiovascular diseases. The consistent agreement between the 
non-invasively imaged activation sequences and its directly measured counterparts in 
both the rabbit heart and canine heart implies that 3DCEI is feasible in reconstructing the 
spatial patterns of ventricular activation sequences, localizing the arrhythmogenic foci, 
and imaging dynamically changing arrhythmia on a beat-to-beat basis. The promising 
results presented in this dissertation study suggest that this cardiac electrical imaging 
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approach may provide an important alternative for non-invasively imaging cardiac 
electrical activity throughout ventricular myocardium and may potentially become an 
important tool to facilitate clinical diagnosis and treatments of malignant ventricular 
arrhythmias.   
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Chapter 1 
Introduction 
 
1.1. Overview 
A group of conditions in which the electrical activity of the heart is irregular or is 
faster or slower than normal, called cardiac arrhythmias, constitutes a major cause of 
death and disability among the world’s population. Particularly, in the United States 
alone, ventricular arrhythmias are the major causes of nearly 400,000 deaths per year 
(Myerburg et al., 1993). Ventricular arrhythmias could occur in patients with either 
structurally normal (e.g., idiopathic arrhythmia) or abnormal (e.g., congestive heart 
failure) hearts, and may degenerate into ventricular fibrillation (VF), an irregular fast 
heart rhythm that could even lead to sudden cardiac death. Both pharmacological 
treatments (Kuck et al., 2000) and electrical stimulation treatments (pacemaker (Hayes et 
al., 2000) and defibrillator (Kerber, 2000; DiMarco, 2003)) are developed and used for 
the intervention of these malignant arrhythmias. In addition, substrate modification is 
also achieved through radio-frequency ablation (Stevenson & Delacretaz, 2000) to 
eliminate critical sites in the heart that initiate the arrhythmias.  
Understanding the electrical activity of the heart and its underlying mechanisms is 
of the great importance for both basic science research and clinical medicine. Cardiac 
electrophysiological mapping emerges as an important tool to aid in both the basic 
research of the arrhythmia mechanisms (Pogwizd et al., 1998) and the clinical treatments 
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(e.g., guiding catheter ablation (Zeppenfeld et al., 2007) or optimizing cardiac 
resynchronization therapy (Spragg et al., 2010)) of malignant arrhythmias. Importantly, 
advancements have been made to map and localize cardiac electrical activity from the 
endocardium using catheter technology, which results in two mapping systems that are 
currently used in the clinical setting (Taccardi et al., 1987; Gepstein et al., 1997; Schalij 
et al., 1998). Though successful, these catheter-based mapping techniques require 
invasive procedure to place the mapping catheter and also require fluoroscopic and/or 
magnetic guidance to accurately steer the mapping catheter in the heart. It is a complex 
procedure which takes considerable time and needs to keep patients in lengthened periods 
of cardiac arrhythmias. In some cases, because of the hemodynamic instability of the 
patient’s arrhythmias, such catheter-based mapping procedure may be difficult to 
perform.  
Therefore, noninvasive diagnosis and imaging of cardiac electrical activity of 
arrhythmia would be of enormous value for numerous patients by allowing cardiologists 
to focus the intervention at the source of the arrhythmia without the need for lengthy 
invasive cardiac mapping. Current routine noninvasive detection and interpretation of the 
cardiac electrical activity is widely performed using 12-lead electrocardiogram (ECG), 
which records the time-varying electrical potentials on the body surface generated by the 
cardiac electrical sources. However, from a fundamental point of view, it is highly 
desirable to non-invasively image and localize the cardiac electrical activity directly in 
the heart from the body surface ECGs. Many investigations have been made to develop 
such noninvasive cardiac electrical imaging techniques to image the epicardial potentials 
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(Barr et al., 1977; Franzone et al., 1978; Yamashita & Takahashi, 1984; Throne & Olson, 
1994; Shahidi et al., 1994; Oster et al., 1997; Greensite & Huiskamp, 1998;  MacLeod & 
Brooks, 1998), activation sequence on the heart surface ( Cuppen & van Oosterom, 1984; 
Huiskamp & Greensite, 1997; Pullan et al., 2001; Tilg et al., 2002; Greensite, 2004), and 
the cardiac electrical activity throughout three-dimentional (3D) myocardium (He & Wu, 
2001; Li & He, 2001; He et al., 2002, 2003; Ohyu et al., 2002; Skipa et al., 2002; Zhang 
et al., 2005; Liu et al., 2006a; Liu et al., 2006b; Nielsen et al., 2007; Liu et al., 2008; Han 
et al., 2008; Wang et al., 2011a; Han et al., 2011, 2012). By providing detailed and 
regional information of the electrical activity of the heart, such techniques are of great 
clinical value in diagnosis and intervention of those malignant arrhythmias.   
 
1.2. Motivations and Significance 
The present dissertation study aims to rigorously evaluate and validate a novel 
physical-model-based three-dimensional (3D) cardiac electrical imaging (3DCEI) 
technique. By combining the functional information obtained from multiple-channel body 
surface ECGs with the subject-specific anatomical information, the 3DCEI technique 
could provide detailed and localized information of the cardiac electrical activity for each 
individual. This 3DCEI technique has a unique feature of imaging and localizing the 
cardiac electrical activity throughout the 3D myocardium, which represents an important 
alternative to other heart surface-based imaging techniques. Furthermore, rigorously 
validation of 3DCEI through both well designed computational study and experimental 
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investigations during different electrophysiological conditions could quantify the 
performance of 3DCEI and thus represents an important step towards further translating 
this technique into clinical use.   
Due to the fact that arrhythmias typically originate from the subendocardium (and, 
at times, from epicardium or even intramural sites (Pogwizd et al., 1998)), it is of 
enormous value for the physician to image cardiac electrical activity and precisely 
localize the origin of arrhythmias throughout the 3D myocardium. The 3DCEI is a novel 
approach that can image the cardiac activation sequence and localize the site of origin of 
activation throughout 3D myocardium. It could overcome the limitation of the invasive 
catheter-based mapping techniques that are currently used in the clinics and advance the 
current noninvasive cardiac electrical imaging techniques that are bounded to heart 
surface. Furthermore, a rigorous validation study during both normal and abnormal 
electrophysiological conditions could demonstrate the potential of 3DCEI for accurately 
localizing arrhythmia areas and characterizing the arrhythmia mechanisms inside the 
heart, thus providing the cardiologists a short cut. The rigorous validation of this 
noninvasive imaging approach may also provide an alternative for noninvasive imaging 
of cardiac activation, thus facilitating the clinical diagnosis of arrhythmias and the 
presurgical planning by substantially reducing risks and expenses associated with the 
invasive procedures that are currently employed in clinical settings.   
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1.3. Scope of the Dissertation 
In chapter 2, a brief literature review is given on the electrical activity of the human 
heart, the ECG, and the background knowledge of noninvasive cardiac electrical imaging 
techniques. Important previous investigations pertinent to the present study are also 
described. 
In chapter 3, the physical-model-based 3DCEI approach is described. Rigorous 
computer simulations are conducted to evaluate the performance of the 3DCEI approach 
for localization of origin of cardiac activation and estimation of cardiac activation 
sequence. Single-site pacing and dual-site pacing protocols in realistic geometry model 
are used in the computer simulation study. 
In chapter 4, experimental investigation in the rabbit heart is conducted to validate 
the performance of the physical-model-based 3DCEI approach. The estimated initiation 
of cardiac activation and the cardiac activation sequence are compared with simultaneous 
measurements from invasive 3D intra-cardiac mapping through plunge-needle electrodes 
in rabbits in a closed-chest condition. Validation study is performed under different 
electrophysiological conditions including pacing and norepinephrine-induced ventricular 
arrhythmias, and reasonable and consistent results are obtained.   
In chapter 5, we extend the experimental investigation of the 3DCEI approach in the 
canine heart, which provides closer approximation to the human heart in terms of cardiac 
size and electrophysiological characters. The noninvasive imaging results are again 
compared with the simultaneous measurements from 3D intra-cardiac mapping. The 
reasonable results demonstrate the feasibility of this novel 3DCEI approach in such large 
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animal model. 
In chapter 6, we perform the experimental investigation of arrhythmia mechanisms 
by applying the 3DCEI approach. This experimental investigation can be categorized into 
2 groups: investigating arrhythmia mechanisms during drug-induce QT prolongation in 
rabbit heart, and investigating arrhythmia mechanisms associated with nonischemic heart 
failure in a canine model. These studies further demonstrate clinical relevance of 3DCEI 
and define the potential clinical role of 3DCEI. 
In chapter 7, the major contributions of the present dissertation research are 
summarized. Recommendations for future works are also discussed. 
The cited literatures, copyright transfer approval and the vita of the author are listed 
at the end of this dissertation. 
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Chapter 2 
Background 
 
2.1. Cardiac Electrical Activity 
The electrical activity of the heart provides the fundamental of the heart functions 
as a pump distributing blood to the lungs and peripheral organs (Widmaier et al., 2005). 
Within a single cardiac cycle, the normal intrinsic electrical conduction of the heart 
allows electrical impulse propagation to be transmitted from the sinoatrial (SA) node 
through both atria and then forward to the atrioventricular (AV) node. Normal physiology 
allows further propagation from the AV node to purkinje fibers, their respective bundle 
branches, and the ventricles. This time ordered electrical conduction system initiates a 
depolarization wavefront that spread throughout the myocardium tissue and thus causes 
efficient and coordinated contraction of the cardiac muscle tissue to provide selective 
blood perfusion through both the lungs and systemic circulation.  
In general, the cardiac electrical activity of myocardium tissue is the result of 
electrochemical reactions of these excitable cells (Malmivuo & Plonsey, 1995). The 
depolarization occurs due to an inflow of sodium ions across the cell membranes. A 
repolarization phrase subsequently follows as a result of potassium ion outflow. The 
transient shift from a resting state to an excited state of cardiac cell defines the action 
potential, a time dependent voltage function, travels from excited, or depolarized, cells to 
neighboring resting cells via low resistance intercellular connectors. 
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2.2. Cardiac Arrhythmias and Electrophysiological Mapping 
A group of conditions in which the electrical activity of the heart is irregular or is 
faster or slower than normal, called cardiac arrhythmias, constitutes a major cause of 
death and disability among the world’s population. Among these ventricular arrhythmias, 
ventricular tachycardia (VT) is a kind of regular and repetitive fast heart rhythm which 
originates in the ventricles of the heart. VT can occur in patients with either structurally 
normal (e.g., idiopathic VT) or abnormal (e.g., congestive heart failure) hearts, and may 
degenerate into ventricular fibrillation (VF), an irregular fast heart rhythm that could 
even lead to sudden cardiac death, and thus is considered as a life-threatening arrhythmia. 
In the past decades, pharmacological treatment of these arrhythmias has been developed 
and used; however it has been shown that pharmacological treatment is difficult 
considering the significant proarrhythmic effects of many antiarrhythmic agents 
(DiMarco, 2003). Recently, electrical stimulation technologies, including implantable and 
wearable defibrillators (Kerber, 2000; DiMarco, 2003), cardiac pacemakers (Hayes et al., 
2000), and cardiac resynchronization therapy (Abraham et al., 2002) have been 
developed for the treatment of these maglignant arrhythmias and their arrhythmogenic 
substrates. In addition, substrate modification has been achieved with radio-frequency 
ablation delivered at the tip of a steerable catheter inserted into the heart through a blood 
vessel (Wood & Morady, 1999; Stevenson & Delacretaz, 2000). In order to eliminate 
critical sites in the heart that initiate the arrhythmias, such cardiac ablation techniques 
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require precise localization of the arrhythmia substrates arrhythmias.  
Cardiac electrophysiological mapping emerges as an important tool to aid in 
diagnosis (e.g., characterizing the electrophysiological substrates and mechanisms of VT 
(Pogwizd et al., 1998)) and clinical treatments (e.g., guiding catheter ablation 
(Zeppenfeld et al., 2007) or implantation of cardiac resynchronization therapy (Spragg et 
al., 2010)) of ventricular arrhythmias. In the past decade, important advancements have 
been made to map and localize cardiac electrical activity from the endocardium using 
catheter technology. There are two mapping systems that are currently used in the clinical 
setting. One is the CARTO electroanatomical mapping system. This is a non-fluorescent 
electroanatomic catheter mapping technique developed using electromagnetic guidance 
of the catheter positioning (Gepstein et al., 1997; Schalij et al., 1998). Based on this 
technique, the investigators are able to record endocardial monophasic action potentials 
(Li et al., 2003), to describe the endocardial electrophysiological substrate for VT (Hsia 
et al., 2003), and to characterize endocardial ventricular activation as a guide for catheter 
ablation in patients with arrythmogenic right ventricular dysplasia (Reithmann et al., 
2003). Another one is the Ensite system, which uses a cavitary noncontact multielectrode 
catheter-probe (that can record beat-to-beat electrical potentials in the blood-filled cavity 
(Taccardi et al., 1987)) to explore the inverse reconstruction of endocardial potentials 
from the potential measurements made on the catheter probe (Khoury et al., 1998; Liu et 
al., 1998; Gornick et al., 1999; Kadish et al., 1999; Jia et al., 2000). Though successful, 
these catheter-based mapping techniques require invasive procedure to place the mapping 
catheter and also require fluoroscopic and/or magnetic guidance to accurately steer the 
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mapping catheter in the heart. It is a complex procedure which takes considerable time 
and needs to keep patients in lengthened periods of cardiac arrhythmias. In some cases, 
because of the hemodynamic instability of the patient’s arrhythmias, such catheter-based 
mapping procedure is difficult to perform.  
2.3. Electrocardiography and Body Surface Potential Mapping 
The thoracic detection of the electrical activity of the heart over a period of time, as 
recorded by electrodes attached to the outer surface of the skin is the electrocardiogram 
(ECG). Current clinically routine noninvasive detection of the cardiac electrical activity 
is widely performed using 12-lead ECG system. The 12-lead ECG system includes three 
bipolar limb leads (lead I to lead III) (Einthoven, 1906), six unipolar precordial leads 
(lead V1 to V6) (Wilson et al., 1934) with reference to the Wilson’s Central Terminal 
(WCT) (Wilson et al., 1944), and three segmented unipolar leads (aVR, aVL, and aVF) 
(Goldberger, 1942). Important diagnosis information could be obtained from the 
interpretation of the waveform of ECG signals.  
Investigations have also been made in developing body surface potential maps 
(BSPMs) techniques, which record a number of ECGs from the multiple sites of the torso 
to depict the instant spatial distribution of these ECG signals over the surface of the torso 
(Taccardi, 1963). In the past 40 years, BSPMs and its variant have been shown by many 
experimental and clinical studies to have higher diagnostic power and be more 
informative than did the 12-lead ECG (Abildskov et al., 1976; Mehra et al., 1983; Mirvis, 
1988; He & Cohen, 1992; Flowers & Horan, 1995; Akahoshi et al., 1997). However, 
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BSPMs have disadvantages in that they cannot provide a detailed electrical source 
distribution within the heart, considering the “smearing” effects of heart-torso volume 
conductor model, which attenuate, distort, and smooth the electrical signals over the body 
surface (Mirvis et al., 1977; Okamoto et al., 1983; Gulrajani et al., 1984). As a 
consequence, many important electrophysiological events do not produce distinguishable 
effects on the body surface, although they can be observed on the cardiac surface or 
within myocardium. 
 
2.2. Cardiac Electrical Imaging  
2.2.1. ECG Forward Problem 
Noninvasive cardiac electrical imaging overcomes the limitation of 12-lead ECG 
and BSPM by imaging and localizing the electrical activity directly in the heart. The 
cardiac electrical imaging techniques include ECG forward problem and ECG inverse 
problem (See Fig.1). The ECG forward problem provides the precondition for such 
noninvasive cardiac electrical imaging techniques through mathematically modeling the 
electrical field between heart and torso. The ECG forward problem entails the calculation 
of densely sampled body surface potentials, starting from the assumed equivalent cardiac 
sources models (e.g., equivalent current density, transmembrane potential, or 
epicardial/pericardial potentials) to represent the cardiac electrical activity. Usually, the 
sources are immersed in a heart-torso volume conductor whose electrical properties and 
geometry are known.  
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In general, the electrical field of the heart-torso volume conductor (Malmivuo & 
Plonsey, 1995) can be governed by the partial differential equations (Poisson's equation 
or Laplace's equation depending on the assumption of the equivalent source models). In 
forward problem, such partial differential equations could be discretized into a set of 
linear equations. Several very important assumptions are hidden behind the forward 
problem (Nash & Pullan, 2005). First, the quasistatic approximation is applied in the 
field, which means at each time instant the body surface potential distribution is solely 
determined by the simultaneous electrical status of the heart sources. Therefore the 
forward problem can be thought of as a series of timely independent problems. Second, in 
most cases, the transfer matrix is assumed to be constant over the time interval during the 
calculation, ignoring the cardiac motion. Conventional imaging modalities like computed 
 
 
Fig. 1, ECG forward problem and ECG inverse problem in cardiac electrical 
imaging.  
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tomography (CT) or magnetic resonance imaging (MRI) are usually used to obtain the 
heart torso geometry. The forward problem has a unique solution; it is always possible to 
calculate the electrical field with certain accuracy, given the details of the source and 
volume conductor (Malmivuo & Plonsey, 1995).   
The computational approaches to the forward problem have been detailed in the 
review papers by Gulrajani (Gulrajani, 1998a, 1998b, 2004). In general, they can be 
mainly categorized into 2 groups: the surface method and the volume method. The 
surface method is also termed the boundary element methods (BEM) (Gelernter & 
Swihart, 1964; Barr et al., 1966; Barr et al., 1977), in which only the interfaces between 
different torso regions/organs are taken into consideration and are digitized and 
represented in the numerical torso model. The different regions/organs are assumed to 
have isotropic conductivity, and the conductivities may vary between different regions. In 
the volume method, the entire three-dimentional (3D) space is represented numerically be 
a combination of tetrahedral and hexahedral (Gulrajani, 2005), and it is the only way to 
incorporate the varying conductivity of individual regions. Usually the volume methods 
include finite element method (Yamashita & Takahashi, 1984; Franzone et al., 1985; 
Pilkington et al., 1985), finite difference method (Walker & Kilpatrick, 1987), and the 
finite volume method (Abboud et al., 1994, Rosenfeld et al., 1996). Compared with 
BEM, the volume methods usually are computationally more demanding. Therefore, 
there are a few studies in combining both the surface method and the volume method, to 
take the advantage of any computational savings afforded by the surface method, while at 
the same time also allow the handling of anisotropies (Pullan, 1996; Fischer et al., 2000). 
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2.2.2. ECG Inverse Problem 
The ECG inverse problem is to reconstruct the source distribution over specified 
volume conductor from body surface potentials through certain mathematical 
manipulation (He & Liu, 2010). Obviously, it is the ECG inverse problem that has 
clinical importance in medical application of bioelectric phenomena (Malmivuo & 
Plonsey, 1995). However, the ECG inverse problem does not possess a mathematically 
unique solution, and there are infinite equivalent cardiac sources which may contribute to 
the same body surface potential distribution.  
In the past decades, many investigations have been made to overcome the difficulty 
of non-uniqueness of ECG inverse problem by using different formulations of equivalent 
cardiac electrical generators. In one of these formulations, cardiac electrical activity has 
been modeled using a few moving current dipoles (Mirvis et al., 1977; Gulrajani et al., 
1984; Armoundas et al., 2003; Lai et al., 2010). Due to the distributed nature of cardiac 
electrical activity, considerable experimental evidence indicates that distributed source 
models are more needed in order to model the distributed cardiac electrical activity. 
Therefore, another formulation, called epicardial potential imaging, which aims at 
reconstructing epicardial potential from BSPMs, has been investigated by several groups 
(Barr et al., 1977; Franzone et al., 1978; Oster et al. 1997,  Yamashita & Takahashi, 1984; 
Shahidi et al., 1994; Throne & Olson, 1994; Greensite & Huiskamp, 1998; MacLeod & 
Brooks, 1998). This approach makes no assumption about the nature of the electrical 
sources in the heart and builds a transfer matrix between epicardial and body surface 
potentials. This method has been previously investigated both via animal experiments and 
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in human subjects, under normal or abnormal cardiac electrophysiological conditions 
(Barr & Spach, 1978; MacLeod et al., 1995; Oster et al., 1997; Burnes et al., 2000; 
Ramanathan et al., 2004; Wang et al., 2011b). An alternative approach called heart 
surface activation imaging has been developed by several groups (Cuppen & van 
Oosterom, 1984; Huiskamp & Greensite, 1997; Pullan et al., 2001; Modre et al., 2002;  
Tilg et al., 2002; Greensite, 2004). In this kind of approach, the cardiac electrical source 
is modeled by an equivalent uniform dipole layer, lining the excited portions of the both 
epicardial and endocardial surfaces. Based on this model, the investigators were able to 
obtain an isochrone map over both epicardial and endocardial surfaces in human subjects 
(Berger et al., 2006; van Dam et al., 2009; Berger et al., 2011). 
Another difficulty of solving ECG inverse problem lies in that the problem is 
mathematically ill-posed, so that small errors in the heart-torso geometry and in the 
measured body surface potentials result in severe instability of the solution. The 
techniques of regularization must therefore be used to suppress the effects of inevitable 
errors due to imposing constrains on the inverse solution. Many regularization techniques 
have been proposed to seek a reliable and physiologically meaningful solution (Tikhonov 
et al., 1977; Hansen & O’Leary, 1993; Johnston & Gulrajani, 1997; Brooks et al., 1999; 
Greensite, 2004).  
It is important to image the cardiac electrical activity throughout the 3D 
myocardium, which may provide direct information for both basic cardiovascular 
research and clinical diagnosis and management of cardiac diseases. Much effort has 
been put in the past decades to extend the ECG inverse problem to achieve this goal (He 
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& Wu, 2001; Li & He, 2001; He et al., 2002, 2003; Ohyu et al., 2002; Skipa et al., 2002; 
Zhang et al., 2005; Liu et al., 2006a; Liu et al., 2006b; Nielsen et al., 2007; Liu et al., 
2008; Han et al., 2008; Wang et al., 2011a; Han et al., 2011, 2012). Among these studies, 
a heart-model-based approach has been proposed to estimate the 3D cardiac electrical 
activity from BSPMs with the aid of a heart-excitation model and a nonlinear 
optimization algorithm (Li & He, 2001; He et al., 2002, 2003). Both the computer 
simulation study (Li & He, 2001; He et al., 2002) and the animal experiment (Zhang et 
al., 2005, Liu et al., 2006a; Liu et al., 2008) showed high consistence between the 
estimated activation sequence and “true” simulated activation sequence or the 
experimentally measured activation sequence. Furthermore, potential distributions are 
estimated throughout the 3D ventricles from BSPMs by this heart-model-based approach 
(He et al., 2003; Liu et al., 2012a). Most recently, a physical-model-based 3D cardiac 
electrical imaging approach (Liu et al.,  2006b) has been proposed to mathematically 
model the cardiac electrical activity using equivalent current density (ECD) distribution 
(He & Wu, 2001), and therefore the 3D cardiac activation sequence could be extracted 
from the inverse solution of ECD distribution. This novel 3DCEI approach only uses the 
general biophysical relationships governing the cardiac electrical activity, and has a 
notable feature of minimal dependence on the physiological knowledge of cardiac 
electrical properties. Therefore, this physical-model-based 3DCEI approach is applicable 
to various cardiac electrophysiology conditions (Han et al., 2008; Han et al., 2011, 2012). 
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2.3. Intracavitary Potential-based Inverse Solution   
In addition to body surface ECG-based inverse solutions, important advancements 
have been made to image and localize cardiac electrical activity from the potentials 
recorded within the blood cavities using catheter technology. In one of the formations, a 
cavitary noncontact multielectrode catheter-probe is used to record the beat-to-beat 
electrical potentials in the blood-filled cavity, which is used for the inverse reconstruction 
of the electrical potentials on the endocardial surface (Taccardi et al., 1987). This 
technique has been previously validated in both animal experiments and clinical research 
by several groups (Khoury et al., 1998; Liu et al., 1998; Gornick et al., 1999; Kadish et 
al., 1999; Jia et al., 2000; Ciaccio et al., 2004). There is one commercially available 
system (Ensite system) that is developed based on this technique. It is noted that while 
this endocardial approach shows promise of offering a minimally invasive means of 
localizing and mapping cardiac electrical activity over the endocardial surface, the 
approach is limited in where activation arises from the myocardial regions far from the 
endocardial surface. Therefore most recently, investigations have been made to extend 
the inverse solution from endocardium into 3D myocardium (He et al., 2007), and both 
the computer simulation (He et al., 2007) and animal experiments (Liu et al., 2012b) 
show the feasibility of this novel method. However, this novel method still requires the 
placement of the catheter with sophisticated clinical manipulations, and it may cause 
clinical complications to those hemodynamically unstable patients. 
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Chapter 3 
Three-dimensional Cardiac Electrical Imaging 
 
2.1. Biophysical Principles and Equivalent Source Model 
The physical-model-based three-dimensional (3D) cardiac electrical imaging 
(3DCEI) approach is developed by mathematically modeling the cardiac electrical 
activity using equivalent source model, and the cardiac excitation information could thus 
be extracted based on fundamental biophysical principles (Liu et al., 2006b; Han et al., 
2008). Most materials in this chapter have been previously published (Han et al., 2008). 
During cardiac excitation, the activation time of each myocardial cell is the latency 
at which the trans-membrane potential (TMP) rises almost instantaneously from the 
resting potential of -90 mV to a plateau potential typically around 0 mV for a normal or 
an abnormal cell. Regardless of the regional difference of the action potential amplitude, 
the activation time is classically characterized by the maximum temporal derivative of the 
TMP waveform. Other than the temporal method for determining the activation time, the 
spatial method provides an alternative and equally effective feature for deriving the 
activation time (Punske et al., 2003). Cardiac excitation propagates as a moving 
wavefront separating the depolarized and non-depolarized myocardium. For a given 
myocardial cell, the activation time can be thought of as the latency at which the 
excitation wavefront passes through the cell. Since a considerable difference of the TMP 
amplitude only exists across the excitation wavefront, a cell at its activation time is also 
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characterized by the maximum TMP spatial gradient (Han et al., 2008). This concept is 
mathematically expressed as Eq. (3.1).  
( ) ( )tm
t
,maxarg rr φτ ∇=        (3.1) 
where ( )tm ,rφ  is the TMP at location r and time t. 
Note that Eq. (3.1) also points to the biophysical principle of a well established 
intra-cardiac mapping technique based on intramural bipolar recordings (Han et al., 
2008). The electrical potential difference between two closely spaced electrodes (i.e. the 
bipolar potential) is approximately a directional component (along the intramural needle) 
of the TMP spatial gradient. Therefore, the time instant with the peak value of the 
absolute bipolar potential precisely corresponds to the activation time with the maximum 
TMP spatial gradient, as defined in Eq. (3.1).  
For any myocardial location r and any time t, we define the equivalent current 
density (ECD) ( )teq ,rjr  to be proportional to the local TMP spatial gradient, as expressed 
by Eq. (3.2)   
( ) ( ) ( )tt mieq ,, rrGrj φ∇−=r         (3.2) 
where ( )rG i  is the intracellular effective conductivity tensor. 
By definition, we have Eq. (3.3) as a consequence of Eq. (3.1) and Eq. (3.2). 
( ) ( )teq
t
,maxarg rjr
r=τ         (3.3) 
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Therefore, the activation time is also characterized by the maximum magnitude of 
the ECD (Liu et al., 2006b). The relationship among the activation time, the TMP and its 
spatial gradient, the ECD and the intramural bipolar potential is illustrated in Fig.2. The 
electrode 1 and electrode 2 record the potentials 1φ  and 2φ , and the recorded time course 
bipolar electrogram at point kr  is given as 21),( φφφ −=trkb . At the instant ( )krt τ= , the 
cardiac cell at point kr  is undergoing depolarization, which is represented by ECD 
( )trkeq ,jr . The angle between the direction of the transmural needle and the direction of 
 
 
Fig. 2, (A) An axial slice of the ventricles, in which the cardiac cells are undergoing 
depolarization. The red region behind the excitation wavefront represents the 
depolarized muscle cells, while the local equivalent current density field over each 
point along this wavefront, indicated by black arrow, represents propagation direction 
of the wavefront at these points. A transmural needle is inserted in the ventricular 
myocardium. (B) The time course of the transmembrance potentials (left panel) and 
the time course of the magnitude of local equivalent current density. (From Ref. (Han 
et al., 2008) with permission © IEEE 2008) 
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ECD ( )trkeq ,jr  is θ . The relationship between the magnitude of local ECD and recorded 
bipolar electrogram can be mathematically described as  
( ) ( ) θ
φ
cos
),(
,
d
trrg
tr kbkkeq =j
r
       (3.4) 
where d  is the distance between electrode 1 and electrode 2, and ( )krg  is the 
conductivity at position kr  (Han et al., 2008). 
 
3.2. Imaging Principles 
3.2.1. Forward Problem 
Based on the bidomain theory (Miller & Geselowitz, 1978; Tung, 1978), the 3D 
distributed ECD can be regarded as the electrical “source” model accounting for the 
extracellular potential “field”, as shown in the following governing equation.  
( ) ( )( ) ( )[ ] ( )tt eqeei ,, rjrrGrG r⋅∇=∇+⋅∇ φ      (3.5) 
where ( )rG i  and ( )rGe  are the intracellular and extracellular effective conductivity 
tensors respectively, and ( )te ,rφ  is the extracellular potential.  
In 3DCEI, the distributed ECD model is used to represent the 3D cardiac electrical 
activity (Han et al., 2008). Given a tessellated geometrical heart-torso model and the prior 
knowledge of the electrical conductivity of relevant tissues and organs, the extracellular 
potentials measurable over the body surface is linearly related to the 3D ECD distribution. 
Boundary element method (BEM) is applied to discretize the above equation, and this 
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linear relationship can be expressed using a matrix-vector notation in Eq. (3.6) 
)()( tt LJΦ =           (3.6) 
where )(tΦ  is the vector of body surface potential distribution at M electrode positions 
and )(tJ  is the vector of 3D ECD distribution at N know myocardial sites at instant t. L is 
the NM 3× source-to-sensor transfer matrix. 
3.2.2. Inverse Problem 
The concept of the ECD as well as its “source” interpretation according to the 
bidomain theory allows to relate the imaging contrast (i.e. activation time) to the 
measurement (i.e. body surface potentials) through well defined equations from Eq. (3.3) 
through Eq. (3.6). The linear inverse problem of Eq. (3.6) is solved instant by instant to 
estimate the spatiotemporal ECD distribution from the body surface potentials and then 
derive the activation time from the estimated ECD time course for each individual 
myocardial location (Han et al., 2008).    
The inverse problem is solved using the generalized (Tikhonov et al., 1977) 
Tikhonov regularization method, which aims to search for the solution estimate that 
minimizes 
2
2
2
2
)()()( ttt WJLJΦ λ+−        (3.7) 
where W  is a NN 33 ×  regularization matrix, and λ  is the regularization 
parameter. The regularization matrix is chosen based on the lead-field normalized 
weighted minimum norm (LFN-WMN) estimation (Wang et al., 1992; Pascual-Marqui, 
1995). In addition, a spatiotemporal regularization technique is applied to deal with the 
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noise perturbation (Greensite & Huiskamp, 1998). Briefly, the singular value 
decomposition (SVD) is employed to decompose the spatiotemporal ECG data matrix 
into orthogonal spatial and temporal components. The spatial components that do not 
satisfy the discrete Picard condition (Hansen, 1990) are assumed to be dominated by 
noise perturbation, and thereby are truncated. The LFN-WMN estimation is applied to 
each remaining spatial component and the regularization parameter λ  can be determined 
by the “L-curve” method (Hansen & O’Leary, 1993) instant by instant. The LFN-WMN 
solutions multiplied with the corresponding singular values and temporal components are 
summed to obtain the spatiotemporal ECD estimates. The activation time at each 
myocardial site is then determined from the time course of the estimated local ECD, by 
finding the maximum ECD estimate according to Eq. (3.3) (Liu et al., 2006b).  
 
3.2. Computer Simulation Study  
In order to evaluate the performance of the 3DCEI technique comprehensively, 
compare the results obtained by different inverse algorithms, and help data interpretation 
of the in vivo experimental validation, computer simulations was conducted on a realistic 
rabbit geometry and piece-wise homogeneous heart-torso model (Han et al., 2008). The 
heart-torso model was built from computed tomography (CT) images of a rabbit, and it 
included myocardial tissue, intra-ventricular blood masses, lungs, and the rabbit torso. 
The conductivities were set to be 0.2, 0.67, 0.05, and 0.21 S/m, respectively. The whole 
3D ventricular myocardial volume was discretized into 7625 grid points evenly spaced by 
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1 mm. There were 53 body surface electrode locations uniformly covering the anterior-
lateral chest of the rabbit body surface, which fit the realistic geometry size of the rabbit 
torso, and simulated the in vivo experimental setting. 
A cellular automaton heart model (Li & He, 2001; He et al., 2002, 2003) was 
employed to simulate the ventricular electrical activity using single-site pacing and dual-
site pacing protocols. In the single-site pacing, nine representative pacing sites were 
selected throughout the 3D myocardium of ventricles, which include basal left wall 
(BLW), basal right wall (BRW), basal anterior (BA), basal posterior (BP), middle left 
wall (MLW), middle right wall (MRW), middle anterior (MA), middle posterior (MP), 
 
 
Fig. 3, Comparison between the forward simulation activation sequence and imaged 
activation sequence during the single-site pacing simulation in computer simulation 
study. (A) Activation was paced at basal lateral wall of the left ventricle (LV). (B) 
Activation was paced at middle lateral wall of right ventricle (RV).  (From Ref. (Han 
et al., 2008) with permission © IEEE 2008) 
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and apex. A dual-site pacing protocol was used to simulate more complex excitation than 
that of the single-site pacing. Eight pairs of pacing sites were selected throughout the 3D 
myocardium of ventricles, which include basal right wall (BRW), basal posterior (BP), 
middle left wall (MLW), middle right wall (MRW), middle anterior (MA), and middle 
posterior (MP). With the setting that maximum peak-peak value is 3 mV determined from 
actual ECG data, Gaussian white noise (GWN) of 20 μV was added to the BSPMs 
generated by the BEM-based forward computation (Han et al., 2008).  
In order to study the performance of 3DCEI under different noise levels and 
electrode numbers, GWN of various noise levels (0, 5, 10, 20, 40, and 60 μV) and 
different electrode numbers (197, 160, 120, 80, and 40 electrodes) were considered 
during the simulation study under single-site pacing.  
Relative error (RE) was calculated to evaluate the dissimilarity between the imaged 
activation sequence and simulated “true” activation sequence. Localization error (LE) 
was calculated to measure the capability of localizing the origin of excitation during 
single-site pacing. RE is defined as  
( )
( )∑
∑
=
=
−
= n
i
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i
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i
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i
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1
2
1
2
        (3.8) 
where n is the number of grid points of the heart model, and  EiAT and 
T
iAT  are the 
estimated activation time and simulated “true” activation time at the i-th myocardial grid 
point, respectively. The LE is defined as the distance between the simulated “true” pacing 
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site with earliest activation and the center of mass of the myocardial region with the 
earliest imaged activation time. 
3.2.1. Preliminary Results 
Fig.3 shows examples of comparison between the imaged activation sequence and 
simulated “true” activation sequence during computer simulation under 20 µV GWN and 
53 electrodes in a single-site pacing protocol. As shown in Fig.3.A, the imaged pattern 
coincided well with the simulated activation sequence, with RE = 0.16. The left ventricle 
 
 
Fig. 4, Comparison between the forward simulation activation sequence and imaged 
activation sequence during the dual-site pacing simulation in computer simulation 
study. (A) Activation was simultaneously paced at middle left wall (MLW) and 
middle anterior (MA) of ventricles. (B) Activation was simultaneously paced at 
basal right wall (BRW) and middle anterior (MA) of ventricles. (From Ref. (Han et 
al., 2008) with permission © IEEE 2008) 
    
27 
 
pacing site was localized with LE = 3.86 mm. Similar imaging performance was 
observed when the activation was induced by pacing at the middle lateral wall of the right 
ventricle, as shown in Fig.4.B, with RE = 0.19 and LE = 4.69 mm. Fig.4 shows examples 
of simultaneous dual-site pacing under 20 µV GWN and 53 electrodes. As shown in 
Fig.4.A, the imaged activation sequence is consistent with the simulated activation 
sequence, which is simultaneously paced at MLW and MA. The quantitative comparison 
gives an RE = 0.17 which shows that our 3DCEI can reconstruct the activation sequence 
throughout the ventricles for dual-site pacing at two separate locations Fig.4.B shows 
another example of simultaneous dual-site pacing at BRW and MA, with RE = 0.21. 
Quantitative comparison between imaged activation sequence and simulated “true” 
activation sequence under both single-site pacing and dual-site pacing with respect to the 
different location of the origin of the ventricular excitation are summarized in Table 1 
and Table 2. On average, RE was 0.20±0.07 and LE was 4.56±1.12 mm for single-site 
pacing. For dual-site pacing, averaged RE was 0.25±0.06. However, it is also observed in 
simulation results that the imaged activation sequence is initialized later and ended earlier 
than the “true” activation sequence, and therefore, the total activation time (TAT) is 
smaller than the imaged activation sequence. 
To evaluate the performance of 3DCEI under various disturbances, simulation work 
was also done under different noise level and different numbers of body surface 
electrodes via single-site pacing protocol. Fig.5 shows the dissimilarity of simulated 
“true” activation sequence and imaged activation sequence, quantified as RE, under 
various noise levels and numbers of electrodes. Fig.6 shows the error for localizing the 
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origin of activation. These results show that the performance of 3DCEI decreases during 
the increase of noise level and the decrease of electrode number. However, even under 
high noise level (e.g. 60 μV GWN) and low electrode number (40 electrodes), reasonable 
result was still obtained as RE of 0.25 and LE of 5.3 mm. Such results show the 
robustness of 3DCEI against measurement noise and effects of the electrode number. 
3.2.2. Discussion 
Computer simulation aims to assess the capability, accuracy, and limitation of 
3DCEI under a realistic and well-controlled environment, and thus provides us the 
reference for understanding the in vivo experimental data. In the present preliminary 
study, we have evaluated the performance of the 3DCEI approach in a simulated rabbit 
 
 
Fig. 5, Relative error under single-site pacing with varying electrode numbers and 
noise levels in computer simulation study. 
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model. A realistic geometry rabbit heart-torso volume conductor model was built from 
the CT images of a rabbit, and computer simulations were conducted to image the 
activation sequence under pacing protocol (Han et al., 2008). Under a 20 µV noise level 
and 53 body surface electrodes, the averaged RE and LE (over 9 pacing sites) were 0.20 
and 4.56 mm for single-site pacing, and the average RE was 0.25 (over 8 pairs of dual-
site) for dual-site pacing. Meanwhile, even under a high noise level (60 µV) and low 
electrode number, reasonable results were still obtained, which suggest the robustness of 
this approach against additive noise and effects of electrode number. 
However, the need to solve a highly ill-posed linear inverse problem in order to 
estimate the ECD from body surface measurements poses a great challenge to 3DCEI 
(Han et al., 2008). Solving such an inverse problem is essentially a task of seeking a 
 
 
Fig. 6, Localization error under single-site pacing with varying electrode numbers 
and noise levels in computer simulation study. 
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spatial filter (or inverse operator) that projects the recorded data in the sensor space to the 
solution in the source space. It is often experienced in the ECG (as well as EEG/MEG) 
inverse problem that applying such a spatial filter cannot lead to a source reconstruction 
in perfect agreement with the true source distribution (Grave de Peralta-Menendez & 
Gonzalez-Andino, 1998). Instead, the source estimates may appear as a spatially blurred 
image, from which one may still resolve the true sources if they are distributed in a 
discrete or focal manner (He & Wu, 2001). But when the current sources are 
continuously distributed over a wavefront during the paced ventricular activation, the 
imaged ECD distribution at any specific time point is highly distinct from being a 
transmural surface as one may expect for the instantaneous excitation wavefront, and it is 
difficult to accurately reconstruct the instantaneous ECD distribution. 
In 3DCEI, the activation time is determined exclusively from the time course of local 
Table 1, Simulation results of imaging the 3D ventricular activation sequence 
induced by single-site pacing. 
 
Pacing Site RE LE (mm) 
BLW 0.16 3.86 
BRW 0.20 4.32 
BA 0.19 3.61 
BP 0.32 6.40 
MLW 0.18 3.61 
MRW 0.19 4.69 
MA 0.14 3.61 
MP 0.31 6.40 
Apex 0.15 4.58 
Mean 0.20±0.07 4.56±1.12 
 
Note: RE, relative error; LE, localization error; BLW, basal left wall; BRW, basal 
right wall; BA, basal anterior; BP, basal posterior; MLW, middle left wall; MRW, 
middle right wall; MA, middle anterior; MP, middle posterior. (From Ref. (Han et 
al., 2008) with permission © IEEE 2008) 
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ECD estimates. Surprisingly, we found that the ill-posed nature caused much less 
distortion to the normalized temporal waveform of ECD estimates than it did to the 
instantaneous ECD spatial distribution (Han et al., 2008). At a noisy condition, the ECD 
spatial distribution was found to be hardly interpretable, whereas the estimated ECD 
waveform at each individual myocardial site still demonstrated a clear peak instant that 
was determined as the activation time. Regarding this finding, our speculated explanation 
is twofold (Han et al., 2008). First, the activation time is a magnitude-independent 
temporal feature of local ECD estimates; therefore it is less sensitive to the spatial 
distortion of the inverse solution. It is true that the torso volume conductor behaves as a 
spatial filter and the estimation of the equivalent current density is essentially the de-
convolution of this spatial filter. However, even though both forward and inverse 
procedures operate upon the spatial domain, the bias and blurring of the inverse solution 
Table 2, Simulation results of imaging the 3D ventricular activation sequence 
induced by dual-site pacing 
 
Pacing Site 1 Pacing Site 2 RE 
BP BLW 0.38 
MRW MLW 0.26 
BP MLW 0.28 
BRW MA 0.21 
BP MLW 0.24 
MLW MLW 0.23 
MLW MA 0.17 
MP MLW 0.25 
Mean 0.25±0.06 
 
Note: RE, relative error; BP, basal posterior; BLW, basal left wall; MRW, middle 
right wall; MLW, middle left wall; BRW, basal right wall; MA, middle anterior; 
MP, middle posterior. (From Ref. (Han et al., 2008) with permission © IEEE 2008) 
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in space also necessarily affects the time course of the source estimate. This effect may 
be well accounted for by a low-pass filter. Importantly, this effect does not significantly 
bias the peak instant which marks the activation time, since the “peak instant” of the 
source time course is a “low-frequency” feature. But this effect may cause the ambiguity 
and potential bias of other competitive methods based on determining the activation time 
from the maximum positive or minimum negative derivative, which is a “high-
frequency” feature, of the estimated TMPs, or the estimated epicardial or endocardial 
potentials. In this sense, it represents another technical merit and robustness of 3DCEI. 
Second, the cardiac excitation process is typically continuous and smooth in nature and 
so is the point spread (or cross-talk) function of the 3D ECG inverse solution. In other 
words, the source estimates at any specific location are primarily affected by the source 
activities at neighboring sites with similar activation times.  
The ill-posed problem of the ECD estimation is still the primary source of the 
activation imaging bias of 3DCEI (Liu et al., 2006b; Han et al., 2008). Because of the 
spatial blurring and bias of the inverse solution, the estimated ECD time course was also 
smooth over time, as compared with the theoretical delta function at the same site. This 
distinction accounted for the reduced specificity of activation time estimation. As a 
consequence, different myocardial locations within an extended region, particularly those 
that are activated around the middle of the QRS interval, often had the identical 
activation time, although they were actually activated progressively. In addition, it also 
caused the total activation time (TAT) obtained from the imaged activation sequence to 
be shorter than the TAT determined from the intra-cardiac data (Han et al., 2008). 
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In summary, the computer simulation work provides a comprehensive evaluation of 
the performance of the 3DCEI. The present results show that 3DCEI is in general capable 
of localizing the origin of activation and reconstructing the overall activation pattern 
under single-site pacing and dual-site pacing. However, we have also observed that the 
present 3DCEI algorithm has limitation in relatively lower spatial resolution when 
comparing with the simulated “true” activation sequence, which is reflected in shorter 
TAT and smoother time course of estimated current density.  
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Chapter 4 
Experimental Investigation in Normal Rabbit Heart 
 
4.1. Introduction 
Ventricular tachycardia (VT) is a malignant arrhythmia that may degenerate to 
ventricular fibrillation and cause sudden cardiac death. In treatment of this arrhythmia, 
catheter ablation procedures require extensive invasive electrophysiological mapping 
(Dong et al., 2006) to determine the arrhythmogenic substrate, and thus keep patients in 
the electrophysiology laboratory for prolonged periods. Noninvasive cardiac electrical 
imaging techniques offer the potential to help define the underlying electrophysiological 
mechanisms and facilitate therapeutic treatments of cardiac disorders on a beat-to-beat 
basis.  
In the previous chapter, we presented a novel three-dimensional (3D) cardiac 
electrical imaging (3DCEI) approach to image ventricular activation sequence from the 
inversely reconstructed equivalent current densities (ECDs) and evaluated the 
performance of this approach through computer simulation (Han et al., 2008). In this 
chapter, we presented our experimental investigation to rigorously evaluate the imaging 
performance of this novel 3DCEI approach using a well-established 3D intra-cardiac 
mapping procedure  (Pogwizd & Corr, 1987; Pogwizd, 1994, 1995; Chung et al., 1997; 
Pogwizd et al., 1998) during paced rhythms and during VT induced by norepinephrine 
(NE) in the rabbit heart (Han et al., 2011). The 3DCEI imaged results were quantitatively 
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compared with simultaneous intra-cardiac mapping results and imaging performance was 
assessed. This study advances our previous experimental work (Zhang et al., 2005; Han 
et al., 2008) in four important ways: 1) Single-site pacing from a large number of 
subendocardial or subepicardial sites in left ventricle (LV) and right ventricle (RV) 
simulates more realistic single cardiac sources originating from the subendocardium and 
subepicardium, while septal pacing simulates intramural cardiac activation originating 
from the interventricular septum; 2) Simultaneous dual-site pacing was induced to 
evaluate the capability of 3DCEI to image more complex cardiac excitation processes; 3) 
The realistic geometry heart-torso model was constructed from computed tomography 
(CT) scans after the mapping experiment to account for the potential geometrical errors 
related to the preceding open-chest surgery and plunge electrode placement; 4) 3DCEI 
was applied to imaging the activation sequence of clinically-relevant NE-induced VTs. 
Materials in this chapter have been previously published (Han et al., 2011). 
 
4.2. Study Design 
4.2.1. Simultaneous Body Surface Potential Mapping and 3D Intra-cardiac 
Mapping 
Thirteen healthy New Zealand white rabbits of either sex (3.6 to 4.3 kg) were studied 
under a protocol approved by the Institutional Animal Care and Use Committees of the 
University of Minnesota and the University of Alabama at Birmingham (Han et al., 
2011). The protocol has been modified from our previous animal experiments (Zhang et 
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al., 2005). Fig.7 shows the schematic diagram of the experimental protocol. For each 
rabbit, simultaneous body surface potential mapping and 3D intra-cardiac mapping of 
ventricular electrical activities were performed during the experiment. Rabbit was 
sedated with ketamine (35 mg/kg), intubated with a size 3 ET tude, and anesthetized 
using 2% isoflurance. Oxygen and mechanical ventilation were administered as needed. 
Heart rate, blood pressure, and lead electrocardiograms (ECGs) were monitored to ensure 
the stability of hemodynamic during whole mapping study. The torso and limbs of rabbit 
were shaved for placement of surface ECG electrodes. 57-64 repositionable body surface 
potential maps (BSPM) electrodes (3M, St. Paul, MN) were uniformly placed to fully 
 
 
Fig. 7. Schematic diagram of the experimental protocol for validating the 3D 
cardiac electrical imaging (3DCEI) technique with simultaneous measurements 
from 3D intra-cardiac mapping in the rabbit heart. (From Ref. (Han et al., 2011) 
with permission) 
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cover the anterior-lateral chest up to the mid-axillary line. The number of BSPM 
electrodes depends on the surface area of the anterior chest. The heart was exposed via 
median sternotomy, and 20-27 transmural plunge-needle electrodes were inserted in the 
left and right ventricles of the rabbits. Each plunge-needle electrode contained 8 bipolar 
electrode-pairs with an inter-electrode distance of 500 µm (160-216 to intramural sites) 
(Pogwizd & Corr, 1987; Pogwizd, 1995). Septal electrodes were inserted into the anterior 
and posterior intraventricular septum of three rabbits (total of 16 interventricular sites for 
each rabbit). The septal electrode contained 4 bipolar electrode-pairs each separated by 
2.5mm (Pogwizd, 1994). The chest and skin were then carefully closed with silk suture, 
and the mapping electrode wires were externalized above and below the sternotomy 
incision. Rapid single-site and simultaneous dual-site pacing were performed via bipolar 
electrode-pairs on selected plunge-needle electrodes in nine rabbits (rabbits P1-P9). NE 
was infused at 25-100 μg/kg/min (3 minutes at each dose) to induce premature ventricular 
complexes (PVCs) and VTs in another four rabbits (rabbits V1-V4) (Han et al., 2011). 
Bipolar electrograms were continuously recorded from all electrode-pairs together with 
body surface potentials from surface electrodes. Bipolar electrogram data were acquired 
at 1 kHz, using a 256 channels cardiac mapping system (Crescent Electronics, Salt Lake 
City, UT), and stored on a Dell laptop using specifically-designed software. Body surface 
potentials were simultaneously recorded using a 128 channels mapping system 
(Compumedics, Charlotte, NC) at a sampling rate of 1 kHz. The cardiac mapping and 
body surface potential mapping were performed simultaneously on two separate 
recording systems. The time alignment was performed during post data analysis. For each 
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run, the two datasets were synchronized by identifying the first pacing spike for pacing 
data or the first PVC beat for arrhythmia data (Han et al., 2011). 
4.2.2. Ultra Fast Computed Tomography 
At the completion of simultaneous mapping study, two sets of ultra fast CT (UFCT) 
(Philips, Amsterdam, NH, Netherlands) images were obtained on the living rabbit to 
obtain needed anatomical geometry information (Han et al., 2011). One without 
intravenous (IV) contrast (a continuous volume scan with slice thickness of 3 mm from 
the level of the mid neck down to the lower abdomen) was used to construct the rabbit 
torso model and extract the location of BSPM electrodes. Another one with IV contrast 
(from the great vessel level down to the diaphragm with slice thickness of 0.33 mm) was 
obtained for construction of a detailed heart model and 3D localization of plunge-needle 
electrodes. The in-plane resolution of CT images was 512*512 pixels. Ten cc to 12 cc of 
IV contrast (OminipaqueTM) was administered at 1.5 cc/sec to visualize the heart 
chambers. The respiration of rabbit was held during the scan in order to minimize 
respiratory artifact. Continuous ECG was monitored and used for gating CT scanner. 
Fig.7.B shows a realistic geometry heart-torso model and BSPM electrodes configuration 
constructed from UFCT images. At the completion of the above procedures, the rabbit 
was euthanized. Then the chest was re-opened and the plunge-needle electrodes were 
carefully localized as described in (Pogwizd, 1994, 1995) by replacing each with a 
labeled pin. The heart was then excised and fixed in formalin. At a later date, 
photographs and post-operative UFCT scans (Han et al., 2011) were obtained on the 
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formalin-fixed heart with labeled pins to further facilitate precise 3D localization of the 
transmural electrodes (See Fig.7.F). It is noted that while some scatters caused by the 
needles were observed on CT images, we were still able to reconstruct the geometry of 
the ventricular cavities (which were brightly visualized by IV contrast) and localize the 
needles (shown as very bright dot spots). 
4.2.3. 3D Intra-cardiac Mapping 
The measured activation sequence within the 3D ventricular myocardium was 
constructed in a way that was slightly different from the previous method (Zhang et al., 
2005; Han et al., 2008). The intersection between each transmural needle and the heart 
surface, and the orientation of each needle within the 3D ventricular myocardium was 
determined directly from the same CT images used for constructing the detailed heart 
model after the mapping study (Han et al., 2011). Each needle was represented by several 
bright dot points on CT slices. The needle was described as a line, whose parameters 
were best-fitting the orientation of the needle in the 3D space. Based on the determined 
coordinate for the intersection between the needle and the epicardial surface, and the 
prior structure information (e.g., inter-distance between bipolar electrode-pairs) of the 
needle, the coordinates of each eight bipolar electrode-pairs on the plunge needle within 
the heart model were calculated precisely from epicardium to endocardium using a linear 
equation and uniquely determined. An alternative heart surface model was built from the 
post-operative CT images of the isolated heart with labeled pins (representing the sites of 
transmural needles), and the location of each needle within this heart surface model was 
    
40 
 
determined from photographs of the isolated heart. This alternative heart surface model 
was carefully compared with the previous detailed heart model so that the identification 
and localization of the needles in that detailed heart model could be determined 
exclusively and precisely. The corresponding activation time of each recording electrode 
was assigned on the basis of peak criteria (Durrer & van der Tweel, 1954; Durrer et al., 
1970; Pogwizd, 1994, 1995), and then a weighted average interpolation algorithm as 
described in (Zhang et al., 2005) was applied to obtain the complete 3D measured 
activation sequence throughout the ventricular myocardium.  
4.2.4. Data Analysis and Statistical Analysis 
For each rabbit, a commercial software package Curry 6.0 (Compumedics, Charlotte, 
NC) was used for contour detection and segmentation to build the subject-specific 
realistic geometry heart-torso model from UFCT images. This computer model includes 
heart, lungs, blood cavities, and chest surface. This heart-torso model was exported for 
further forward and inverse computation (Han et al., 2011) in a software package we 
developed in MATLAB2007a (MathWorks, Natick, MA). The 3D ventricular 
myocardium was discretized into thousands of grid points. The spatial resolution of the 
ventricular models was 1mm. A distributed ECD model was used to represent the cardiac 
electrical sources within the 3D ventricular myocardium. Given a tessellated geometrical 
heart-torso model and the prior knowledge of the electrical conductivity of relevant 
tissues and organs, the extracellular potentials measurable over the body surface is 
linearly related to the 3D ECD distribution by using the boundary element method. 
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The inverse problem is solved by using the algorithm presented in the previous 
chapter (Han et al., 2008). Briefly, the ECDs are reconstructed by the lead-field 
normalized weighted minimum norm (LFN-WMN) estimation (Wang et al., 1992) in 
combination with a spatiotemporal regularization. The singular value decomposition 
(SVD) is employed to decompose the spatiotemporal ECG data matrix into orthogonal 
spatial and temporal components. The spatial components that do not satisfy the discrete 
Picard condition (Hansen, 1990) are assumed to be dominated by noise perturbation, and 
thereby are truncated. The LFN-WMN estimation is applied to each remaining spatial 
component. The LFN-WMN solutions multiplied with the corresponding singular values 
and temporal components are summed to obtain the spatiotemporal ECD estimates. The 
activation time at each myocardial site is then determined from the time course of the 
estimated local ECD, by finding the maximum ECD estimate according to Eq. (3.3). 
The correlation coefficient (CC), relative error (RE), and localization error (LE) were 
computed to quantify the overall agreement and disagreement between the invasively 
measured activation sequence and the non-invasively imaged activation sequence. LE 
was defined in the previous chapter. The CC and RE are defined as 
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where n is the number of grid points of the heart model, EiAT  and 
M
iAT  are the 
estimated activation time and measurement constructed activation time at the i-th 
myocardial grid point, and EAT  and MAT  are the averaged estimated and measured 
activation time over all n myocardial grid points, respectively.  
 
4.3. Results 
After insertion of plunge electrodes, closure of the chest did not alter heart rate or 
mean arterial blood pressure (232 ± 6 vs 238 ±6 bpm and 62±4 vs 62±3 mm Hg, P=NS vs 
pre-closure) or total activation times of sinus beats (31±1ms vs 29±1ms, P=NS vs pre-
closure), which were consistent with previously published data in control rabbits 
(Pogwizd, 1995; Zhang et al., 2005). The ventricular myocardium was tessellated into 
6250±1137 evenly-spaced grid points. The spatial resolution of the ventricle models was 
1 mm. There were 178±25 intramural bipolar electrodes during 3D intra-cardiac mapping 
and 60±2 BSPM electrodes.  
4.3.1. Validation during Pacing 
Single-site pacing was performed in rabbits P1-P9 (Han et al., 2011). The pacing 
sites were chosen to include multiple regions of LV, RV, and septum. Fig.8.A and 
Fig.8.B show the representative example of the comparison between the measured and 
imaged activation sequence when rabbit P6 was paced respectively at subendocardium 
(Fig.8.A) or subepicardium (Fig.8.B) via a plunge-needle electrode located at anterior 
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basal wall of LV. From the measured activation sequence of the endocardial-paced beat 
in Fig.8.A, the earliest activation was observed at the subendocardium. When the 
wavefront arrived at the epicardium, a relatively large breakthrough was noticed on the 
 
 
Fig. 8, Comparison between the 3D activation sequence measured via 3D intra-
cardiac mapping and the 3D activation sequence imaged by 3DCEI when a rabbit 
was paced respectively at the endocardium (A) and epicardium (B) of LV basal 
anterior wall and when another rabbit was simultaneously paced at epicardium of LV 
apex and anterior basal left wall (C). (From Ref. (Han et al., 2011) with permission) 
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epicardial surface. The wavefront then propagated over the septum, and ended at the 
basal lateral wall of RV. The spatial activation pattern for the epicardial-paced beat in 
Fig.8.B is similar to that of endocardial-paced beat, but the major difference is that the 
origin of the activation from both the measured and the imaged activation sequences is 
located at the subepicardium rather than the subendocardium. For both cases, the imaged 
activation sequence closely approximated the measured activation sequence, with a CC of 
0.76 and an RE of 0.29 for endocardial-paced beat, and a CC of 0.77 and an RE of 0.30 
for epicardial-paced beat. The origin of activation was visually localized at the 
Table 3, Quantitative comparison between measured and imaged activation 
sequences in single-site LV pacing in the rabbit heart.  
 
Rabbit 
No. 
Pacing Needle 
Location 
Endocardial LV Pacing Epicardial LV Pacing 
CC RE LE (mm) CC RE LE (mm) 
P1 LVA 0.71 0.25 4.7 0.67 0.23 3.2 
P2 BLW 0.73 0.33 6.2 0.75 0.31 5.7 
P3 Anterior BLW 0.78 0.30 7.6 0.79 0.32 7.1 
 LVA 0.65 0.27 5.2 0.69 0.27 4.1 
P4 BLW 0.81 0.29 4.6 0.86 0.27 2.7 
 Posterior BLW 0.73 0.34 3.9 0.71 0.33 4.2 
P5 Posterior MLW 0.74 0.34 3.9 0.73 0.32 4.8 
 LVA 0.74 0.32 7.4 0.75 0.29 7.4 
 Anterior BLW 0.63 0.30 4.9 0.61 0.33 4.1 
P6 Anterior BLW 0.71 0.30 3.8 0.75 0.31 2.3 
P7 Anterior MLW 0.79 0.28 3.7 0.81 0.27 3.4 
 Posterior MLW 0.69 0.29 5.1 0.68 0.31 5.0 
P8 MLW 0.72 0.33 4.7 0.73 0.32 5.1 
 BLW 0.75 0.26 3.8 0.74 0.27 3.2 
P9 MLW 0.76 0.31 4.6 0.77 0.32 4.5 
 Mean 0.73±0.05 0.30±0.03 4.9±1.2 0.74±0.06 0.29±0.03 4.5±1.5 
 
Note: LV, left ventricle; CC, correlation coefficient; RE, relative error; LE, 
localization error; BLW, basal left wall; LVA, left ventricle apex; MLW, middle 
left wall. (From Ref. (Han et al., 2011) with permission) 
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subendocardium or subepicardium, with a low LE of 3.6mm and 3.0mm for these two 
cases respectively.  
Septal pacing was performed via the selected plunge-needle electrodes placed in the 
interventricular septum for rabbits P7-P9 (Han et al., 2011). Fig.9 shows a representative 
example when rabbit P9 was paced at base septum via a septal electrode inserted from the 
anterior rabbit ventricles. From the measured map, the activation initiated at the 
intramural septum slightly closer to LV. The wavefront then propagated to the rest of the 
ventricles and terminated at the RV apex. The overall pattern of the imaged activation 
Table 4, Quantitative comparison between measured and imaged activation 
sequences in single-site RV and septal pacing in rabbit heart.  
 
Rabbit No. Pacing Needle Location CC RE LE (mm) 
P1 MRW 0.75 0.30 3.2 
P2 Posterior MRW  0.68 0.31 7.8 
 MRW 0.74 0.29 4.0 
P3 BRW 0.78 0.30 5.6 
P4 Anterior BRW 0.73 0.26 4.3 
 Posterior MRW 0.68 0.36 5.2 
P5 BRW 0.80 0.32 6.3 
 RVA 0.78 0.28 4.9 
P6 Posterior MRW 0.74 0.27 5.5 
 MRW 0.69 0.32 4.7 
P7 Posterior MS 0.67 0.30 5.3 
 Posterior AS  0.72 0.33 7.2 
P8 Posterior AS 0.71 0.29 5.0 
P9 Anterior BS 0.69 0.31 4.7 
 Anterior MS 0.68 0.32 5.8 
 Mean 0.72±0.04 0.30±0.03 5.3±1.2 
 
Note: RV, right ventricle; CC, correlation coefficient; RE, relative error; LE, 
localization error; AS, apex septum; BRW, basal right wall; BS, basal septum; 
MRW, middle right wall; MS, middle septum; RVA, right ventricle apex. (From 
Ref. (Han et al., 2011) with permission) 
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sequence resembled the measured one, with a CC of 0.68, and an RE of 0.29. The 
initiation site was well localized at the septum with an LE of 4.4 mm for this beat.  
A total of 300 beats of LV pacing from 15 selected plunge-needle electrodes were 
analyzed (10 endocardial paced beats and 10 epicardial paced beats for each plunge-
needle electrode). The ability of 3DCEI in reconstructing the overall activation pattern 
and localizing the pacing site during LV pacing in quantitative comparison is summarized 
in Table 3. A slightly better performance of imaging epicardial pacing was observed in 
terms of LE. Another 150 beats of single-site pacing at 10 RV epicardial sites and 5 
septal sites (10 paced beats for each pacing) were analyzed and the quantitative 
comparison is summarized in Table 4. A slight increase of LE was observed during septal 
pacing, as compared to LV pacing. The averaged CC and averaged RE for the 
combination of LV pacing, RV pacing, and septal pacing were 0.73±0.04 and 0.30±0.02 
 
 
Fig. 9, Comparison between the 3D measured activation and the 3D imaged 
activation sequence during septum pacing in rabbit heart. (From Ref. (Han et al., 
2011) with permission) 
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respectively, suggesting excellent agreement between the measured and imaged 
activation sequence. Furthermore, the pacing sites were estimated to be 4.9±1.3mm away 
from the measured ones, suggesting reasonable localization accuracy of this approach 
(Han et al., 2011).  
Dual-site pacing was performed in rabbits P1-P5 (Han et al., 2011). Fig.8.C shows 
the representative comparison when rabbit P3 was simultaneously paced at an LV 
epicardial site in the basal lateral wall and at an LV epicardial site in the posterior apex. 
The two pacing sites were 21mm apart within the heart. The activation ended in the RV 
basal lateral wall. The non-invasively reconstructed activation sequence closely 
resembled the measured one, with a CC of 0.72 and an RE of 0.30. The double origins of 
the activation were clearly resolved from the imaged result. A total of 70 beats of 
simultaneous dual-site pacing from 7 pairs of epicardial pacing sites (10 beats for each 
dual-site pacing) were analyzed. The performance of 3DCEI in imaging dual-site pacing 
Table 5, Quantitative comparison between measured and imaged activation 
sequence in simultaneous dual-site pacing in rabbit heart.  
 
Rabbit No. Pacing Needle Locations CC RE 
P1 LVA, MRW 0.65 0.34 
P2 BLW, Posterior MRW  0.59 0.39 
P3 Anterior BLW, LVA 0.71 0.33 
P4 Anterior BRW, Posterior BLW 0.72 0.33 
P5 BRW, LVA 0.69 0.31 
 RVA, LVA 0.71 0.32 
 Anterior BLW, LVA 0.73 0.34 
 Mean 0.69±0.05 0.33±0.05 
 
Note: CC, correlation coefficient; RE, relative error; BLW, basal left wall; BRW, 
basal right wall; LVA, left ventricle apex; MRW, middle right wall; RVA, right 
ventricle apex. (From Ref. (Han et al., 2011) with permission) 
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in quantitative comparison is summarized in Table 5. The inter-site distance for the two 
pacing sites ranged from 10-27mm. The double origins were identified when they were 
located at contralateral sides of ventricles or at the ventricular lateral wall and the apex, 
respectively. The averaged CC and RE were 0.69±0.05 and 0.33±0.05 respectively, 
suggesting excellent agreement between measured and estimated activation sequences 
when imaging more complex activation pattern other than single-site pacing. 
4.3.2. Norepinephrine-induced Ventricular Arrhythmias 
Isolated PVCs and nonsustained monomorphic VTs were obtained during the 
infusion of NE in rabbits V1-V4. A total of 28 PVCs and 45 beats of VTs were analyzed 
Table 6, Quantitative comparison between measured and imaged activation sequence 
in norepinephrine induced VT in rabbit heart. 
  
Rabbit No. Arrhythmia Type Origin CC RE LE (mm) 
V1 PVC LVA 0.61 0.31 7.4 
 Monomorphic VT BLW 0.70 0.33 5.4 
V2 PVC MRW 0.71 0.30 5.0 
 PVC Posterior MRW 0.69 0.31 3.8 
 Monomorphic VT Anterior MRW 0.77 0.31 6.0 
V3 PVC MRW 0.75 0.32 4.8 
 PVC BLW 0.70 0.30 4.8 
 PVC BRW 0.69 0.31 4.7 
 Monomorphic VT BRW 0.73 0.29 7.1 
V4 PVC BRW 0.69 0.31 4.9 
 PVC Posterior MRW 0.65 0.27 7.1 
 Monomorphic VT BRW 0.68 0.32 4.0 
Mean 0.70±0.04 0.31±0.02 5.4±1.2 
 
Note: VT, ventricular tachycardia; CC, correlation coefficient; RE, relative error; PVC, 
premature ventricular complex; BLW, basal left wall; BRW, basal right wall; LVA, left 
ventricle apex; MRW, middle right wall. (From Ref. (Han et al., 2011) with 
permission) 
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and the mechanism of the arrhythmia was defined for all these ectopic beats from intra-
cardiac mapping. All these PVC and VT beats initiated in the subendocardium and did so 
by a focal, and what we believe to be a nonreentrant mechanism (Han et al., 2011), based 
on the lack of intervening electrical activity between the preceding beat and the initiation 
of the ectopic beat in intramural recordings (Pogwizd, 1995; Pogwizd et al., 1998). PVCs 
in each rabbit demonstrated different initial sites of activation, except rabbit V1 which 
had PVCs only initiated from a single site. Seven PVCs initiated in the LV and 21 in the 
RV. PVCs initiated with a coupling interval of 279±39ms and conducted with a total 
activation time of 46±9ms. The averaged coupling interval among all maintained VT 
beats was 216±11ms, and the averaged total activation time was 48±7ms. The 
quantitative comparison for PVCs and VTs beats is summarized in Table 6. 
 Fig.10.A-Fig.10.C show the comparison between the measured and imaged 
activation sequences for three PVC beats in rabbit V3. Different activation patterns were 
observed, with different initiation sites at subendocardium of basal right wall, basal left 
wall, and middle right wall respectively. The imaged results resembled the measured 
counterparts, with a CC of 0.69 and an RE of 0.31 for PVC in Fig.10.A, a CC of 0.71 and 
an RE of 0.29 for PVC in Fig.10.B, and a CC of 0.78 and an RE of 0.28 for PVC in 
Fig.10.C. The initiation sites were estimated to be 4.8mm, 3.6mm, and 4.5mm from the 
measured sites respectively.  
An example of a representative VT beat in a six-beat monomorphic VT in rabbit V1 
is shown in Fig.10.D. After initiation, all VT beats looked similar. As shown in the 
measured activation sequence, the VT beat initiated within subendocardium by a focal 
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(nonreentrant) mechanism at the basal lateral wall of LV. After initiation, activation 
propagated to the RV and terminated at base of RV with a total activation time of 42ms. 
 
 
Fig. 10, Comparison between the 3D measured activation sequence and the 3D 
imaged activation sequence during premature ventricular complex and ventricular 
tachycardia induced by norepinephrine in the rabbit heart. (From Ref. (Han et al., 
2011) with permission) 
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The imaged activation sequence matched measured one, with a CC of 0.76 and an RE of 
0.30. The initiation of the activation was well localized with an LE of 4.8mm.  
 
4.4. Discussion 
The present study in this chapter aims to assess the performance of the 3DCEI 
technique in non-invasively reconstructing the 3D ventricular activation sequence and 
localizing the origin of activation in the in vivo rabbit heart (Han et al., 2011). By 
comparing the imaged results with simultaneous measurements through 3D intra-cardiac 
mapping from up to 216 intramural sites, this study validated the ability of 3DCEI to 
identify, locate and resolve single and double electric events during single-site and dual-
site paced rhythms, as well as NE-induced nonsustained monomorphic VTs and PVCs. 
Our results showed an excellent agreement of the spatial activation pattern between the 
non-invasively imaged activation sequence and its directly measured counterparts, as 
quantified by a CC of 0.72 and an RE of 0.30 averaged over all paced and ectopic beats. 
The origins of the activation in imaged results had an averaged distance of ~5mm from 
the pacing sites for the single-site paced beats (450 beats at 45 pacing locations in 9 
animals) and site of initiation for ventricular ectopic beats determined by intra-cardiac 
mapping (73 beats in 4 animals). These findings imply that 3DCEI is feasible in 
reconstructing the spatial patterns of 3D ventricular activation sequences, localizing the 
focal or multiple arrhythmogenic foci, and imaging dynamically changing arrhythmia on 
a beat-to-beat basis (Han et al., 2011). 
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Rigorous validation studies in biological systems are crucial for establishing any 
imaging methods. Compared with other animal experiments and human studies (Oster et 
al., 1997; Berger et al., 2006; Ghosh et al., 2008) in validating epicardial potential and 
heart surface activation imaging techniques, the present study has used a novel in vivo 
experimental design in which BSPMs were obtained simultaneously with intramural 
electrical recordings from plunge-needle electrodes in a closed-chest condition, and thus 
provided quantitative assessments of the 3DCEI approach. The experimental protocol has 
been refined from our previous studies (Zhang et al., 2005; Han et al., 2008) in using CT 
images obtained on the anesthetized animals immediately following the mapping studies. 
Such improvements could more accurately model the heart-torso geometry by 
considering certain effects related to the procedures of open-chest surgery (e.g., rotation 
of the heart orientation and position-shift of BSPM electrodes) and more accurately 
determine the location of the plunge-needle electrodes within the detailed heart model, as 
compared with previous studies (Han et al., 2011).  
The present physical-model based 3DCEI approach only uses the general biophysical 
relationships governing the cardiac electrical activity, without incorporating any 
physiological assumptions. The activation sequence throughout 3D ventricular 
myocardium was estimated based on the inversely reconstructed ECDs from the BSPMs. 
Like other studies (Oster et al., 1997; Tilg et al., 2002), we experience smoothing effects 
when we solve the inverse problem, especially at the earliest and latest activation times, 
when body surface potentials are of relatively small magnitudes compared to noise. The 
resultant solution may lead to spatially smoothed images, and thus cause the delayed 
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initiation and premature termination. Nevertheless, the imaged activation sequence still 
provided a close match to the direct measurements, suggesting that significant 
information regarding ventricular excitation has been preserved in imaged results. Such 
information revealed the activation pattern within a single map and helped identify the 
initiation sites in the endocardium, epicardium or intramural septum (Han et al., 2011). 
For the first time, the 3DCEI approach was applied in imaging ventricular 
arrhythmias and validated with the aid of 3D intra-cardiac mapping (Han et al., 2011). 
NE simulated the activation of the sympathetic nervous system and induced PVCs and 
VTs. The measured activation sequence also showed that these arrhythmias usually 
originated within the subendocardium and may arise from Purkinje cells or 
subendocardial myocardium. The origins have been well localized by the noninvasive 
3DCEI approach with good accuracy, implying that this approach may be valuable for 
imaging focal ventricular arrhythmias arising in the deeper myocardium. For the earliest 
activation onset, it is possible that PVCs and VT beats may initiate close to the plunge 
electrode that records earliest electrical activity. However, mapping at the resolution that 
we employed in this study (recording from 200 intramural sites in the rabbit heart is 
equivalent to recording from up to 2600 intramural sites in the canine heart) (Pogwizd, 
1995) and having each bipolar initiation site surrounded by several dozen intramural 
recording sites that recorded later activity, we minimized the effects of extrapolation so 
that we anticipated earliest onset to be immediately adjacent to the earliest recording site 
(Pogwizd, 1995).  
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Our results indicated that the site of earliest activation was always in close proximity 
to the measured initiation site, with an averaged distance from imaged and measured sites 
to be ~5mm (Han et al., 2011). While the noninvasive imaging approach would enable 
the clinical electrophysiologist to localize to within ~5 mm of the myocardium region 
from which focal activation is arising, additional catheter mapping would certainly be 
required to more precisely localize this focal site for the ensuing ablation. The key values 
of this approach would be to shorten the ablation time and, perhaps more importantly, to 
help determine whether initiation is arising in the endocardium or the epicardium (which 
would also shorten ablation time since epicardial ablation requires a pericardial approach, 
and this is often initiated after endocardial catheter mapping suggests an epicardial site of 
origin). This study also extended the evaluation in imaging relatively more complex 
activation pattern, as simulated by dual-site pacing (Han et al., 2011). This has specific 
clinical relevance when more than one arrhythmogenic activity (e.g., two pre-excitation 
sites or fusion beat) are taking place simultaneously, and it would then be imperative to 
know the locations of these electric events before ablation. Furthermore, dual-site pacing 
simulates the cardiac resynchronization therapy (Abraham et al., 2002), which is an 
important clinical procedure in treatment of heart failure patient and may have potential 
clinical applications in this area. 
In conclusion, the present study suggests that the 3DCEI approach can reconstruct 
3D ventricular activation sequence and localize the origin of activation during pacing and 
focal ventricular arrhythmias, as validated by 3D intra-cardiac mapping in the rabbit 
heart. It also implies the potential application of 3DCEI as a clinically useful tool to aid 
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in localizing the origins of ventricular arrhythmias and understanding the mechanism of 
these arrhythmias. 
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Chapter 5 
Experimental Investigation in Normal Canine Heart 
 
5.1. Introduction 
In the previous chapter, we have rigorously validated the three-dimensional (3D) 
cardiac electrical imaging (3DCEI) approach using 3D intra-cardiac mapping in the 
normal rabbit heart during pacing and ventricular tachycardia (VT) (Han et al., 2011). 
The present study extends the validation of this novel 3DCEI approach using the well-
established 3D intra-cardiac mapping procedure (Pogwizd & Corr, 1987; Pogwizd, 1994, 
1995; Pogwizd et al., 1998; Han et al., 2008; Han et al., 2011) in the canine heart which 
is closer to the human heart in cardiac size and electrophysiological characteristics (Han 
et al., 2012). Plunge-needle electrodes were placed in the left ventricle (LV) and right 
ventricle (RV), and the body surface potentials and intramural bipolar recordings were 
measured simultaneously in a closed-chest condition. Pacing was performed at the 
subendocardium and subepicardium of the canine ventricles. Furthermore, 
norepinephrine (NE) was infused to induce ventricular ectopic activities including 
multiform premature ventricular complexes (PVCs), couplets, and runs of nonsustained 
monomorphic VTs (MVTs) and polymorphic VTs (PVTs). The 3DCEI imaging results 
were quantitatively compared with the intra-cardiac mapping results to assess the 
imaging performance. Materials in this chapter have been previously published (Han et 
al., 2012). 
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5.2. Study Design 
5.2.1. Canine Model and Experimental Procedures 
Five healthy control canines (of either sex) were studied under a protocol of 
simultaneous body surface potential mapping and 3D intra-cardiac mapping of 
ventricular electrical activity (Han et al., 2012). The protocol was approved by the 
Institutional Animal Care and Use Committees of the University of Minnesota and the 
University of Alabama at Birmingham. Fig.11 shows the schematic paradigm of the 
experiment. Each canine was anesthetized using 0.04 mg/kg intramuscular atropine and 
~20 mg/kg intravenous (IV) pentothal. The animal was then intubated and placed on a 
ventilator. Anesthesia was maintained with 2-3% isoflurane delivered in 100% oxygen. 
Up to 124 repositionable BSPM electrodes (3M, St. Paul, MN) were uniformly placed to 
cover both the anterior and posterior chest, and up to 42 transmural plunge-needle 
electrodes were inserted in the LV and RV (up to 216 intramural sites). Each LV plunge-
needle electrode contains 4 bipolar electrode-pairs (inter-electrode distance of 500 μm) 
each separated by 2.5mm (Pogwizd, 1994; Pogwizd et al., 1998), and each RV electrode 
contains 8 bipolar electrode-pairs with an inter-electrode distance of 500 µm (Pogwizd, 
1995). The chest and skin were then carefully closed with silk suture, and the mapping 
electrode wires were externalized above and below the sternotomy incision. Bipolar 
electrograms were continuously recorded from all electrode-pairs together with body 
surface potentials from surface electrodes. Bipolar electrograms were acquired at 1 kHz, 
using a 256 channels cardiac mapping system (Crescent Electronics, Salt Lake City, UT). 
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Body surface potentials were simultaneously recorded using a 128 channels mapping 
system (Compumedics, Charlotte, NC) at a sampling rate of 1 kHz. 
During pacing study, rapid pacing were performed (for 10-20 secs) in canines C1-C5 
via bipolar electrode-pairs on selected plunge-needle electrodes located at 
subendocardium and subepicardium of the ventricles using a specially-designed junction 
box. Furthermore, NE was infused to induce ventricular arrhythmias including PVCs, 
couplets, nonsustained MVTs, and PVTs in canines C3-C5 after the pacing study (Han et 
al., 2012).  
At the completion of simultaneous mapping study, two sets of ultra fast computed 
tomography (UFCT) (Philips, Amsterdam, NH, Netherlands) images were obtained on 
 
 
Fig. 11, Schematic diagram of the experimental protocol for validating the 3D 
cardiac electrical imaging (3DCEI) technique with simultaneous measurements from 
3D intra-cardiac mapping in the canine heart. (From Ref. (Han et al., 2012)) 
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the living animal to obtain the anatomical information (Han et al., 2012). One without IV 
contrast (a continuous volume scan with slice thickness of 3mm from the level of the mid 
neck down to the lower abdomen) was used to construct the torso model and extract the 
location of BSPM electrodes. Another one with IV contrast (from the great vessel level 
down to the diaphragm with slice thickness of 0.33mm) was obtained for construction of 
a detailed heart model and 3D localization of plunge-needle electrodes. The in-plane 
resolution of UFCT images was 512*512 pixels. 30 cc of IV contrast was administered at 
3.0cc/sec to visualize the heart chambers during the cardiac UFCT scan. The plunge-
needle electrodes were then carefully localized as previously described in (Han et al., 
2011) by replacing each with a labeled pin. A post-operative UFCT scan of the formalin-
fixed canine heart was subsequently performed to further facilitate precise 3D 
localization of the transmural electrodes.  
5.2.2. Data Analysis 
The physical-model-based 3DCEI approach was used to non-invasively reconstruct 
the activation sequence throughout the 3D ventricular myocardium. The forward 
modeling and inverse computation of the 3DCEI approach were described in the previous 
chapters. Briefly, the realistic geometry heart-torso model was constructed from UFCT 
images for each animal, using a commercial software package CURRY 6.0 
(Compumedics, Charlotte, NC). This heart-torso model was exported for further forward 
and inverse computation (Han et al., 2011, 2012). The electrical conductivities were set 
to 0.2, 0.67, 0.05, and 0.21 S/m respectively. The algorithm presented in the previous 
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chapters was used to solve the inverse problem and reconstruct the 3D activation 
sequence. 
The performance of 3DCEI was evaluated by comparing the non-invasively imaged 
activation sequence with the simultaneously direct measurements obtained from 3D intra-
cardiac mapping. The measured activation sequence within the 3D ventricular 
myocardium was constructed to allow for a quantitative comparison. The orientation and 
location of each needle within the 3D ventricular myocardium was determined directly 
from the same UFCT images used for constructing the detailed heart model after the 
mapping study and therefore the 3D measured activation sequence was reconstructed 
(Han et al., 2011, 2012).  
Numerical data are presented as mean ± SD. The correlation coefficient (CC) and 
relative error (RE) were computed respectively to quantify the agreement of overall 
activation pattern and the consistency of the activation time between the invasively 
measured activation sequence and the non-invasively imaged activation sequence. CC 
and RE were defined in Eq. (4.1) and Eq. (4.2) respectively. The root mean square error 
(RMSE) was computed to quantify the timing difference between measured and imaged 
activation sequences. The RMSE is defined as 
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      (5.1) 
where n is the number of grid points of the heart model, E
iAT  and MiAT  are the non-
invasively estimated activation time and measurement constructed activation time at the 
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i-th myocardial grid point. EAT  and MAT  are their respective mean values. The 
localization error (LE), was computed to evaluate the performance of 3DCEI in 
localizing the origin of activation. Statistical significance of differences was evaluated by 
Student’s t-test (paired or unpaired) and ANOVA test, and a p value < 0.05 was 
considered statistically significant (Han et al., 2012).  
 
 
Fig. 12, Comparison between the 3D measured activation sequence and the 3D 
imaged activation sequence when canine was paced at the subepicardium (A) and 
subendocardium (B) of middle lateral wall of left ventricle. (From Ref. (Han et al., 
2012)) 
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5.3. Results 
5.3.1. Experimentation and Modeling 
Five canines were studied during the in vivo experiments. After insertion of plunge-
needle electrodes, closure of the chest did not alter heart rate or mean arterial blood 
pressure (115±15 versus 120±20 bpm, p>0.05, paired t-test, and 60±3 versus 57±6 mm 
Hg, p>0.05, paired t-test) or total activation times of sinus beats (43±2ms versus 44±2ms, 
p>0.05, paired t-test) for each canine (Han et al., 2012). The realistic geometry heart-
torso model was constructed for each animal from two sets of UFCT images obtained 
after the mapping study. The ventricular myocardium was tessellated into 21332±7036 
evenly-spaced grid points. The spatial resolution of the ventricle models was 1.5 mm. 
There were 200±10 intramural bipolar electrodes during 3D intra-cardiac mapping and 
114±7 BSPM electrodes on the canine body surface. 
5.3.2. Pacing in the Canine Heart  
Simultaneous body surface potential mapping and 3D intra-cardiac mapping were 
performed under single-site pacing in canine C1-C5 (Han et al., 2012). The pacing sites 
were chosen to include multiple regions of the LV and RV. Fig.12 shows a representative 
example of the comparison between the measured and imaged activation sequences when 
canine C2 was paced respectively at subepicardium and subendocardium via a plunge-
needle electrode located in the left lateral free wall midway between the base and the 
apex. The spatial distribution of the activation time within the ventricular myocardium is 
color-coded. The white corresponds to early activation, while blue corresponds to late 
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activation. The left column shows the comparison of the activation sequence on the 
epicardial and endocardial surfaces. The right column shows four axial slices starting 
from ventricular base. The subendocardial and the subepicardial sites of origin were 
identified for these two cases respectively from the imaged activation sequence. The 
overall pattern of the imaged activation sequence closely approximated the measured one 
during early and middle activation, while a slight difference was observed during late 
activation. The quantitative comparison gave a CC of 0.72, an RE of 0.25, and an RMSE 
Table 7, Quantitative comparison between measured activation sequence and imaged 
activation sequence during single-site LV pacing in the canine heart.  
 
Canine Pacing Needle 
Location 
Endocardial LV Pacing Epicardial LV Pacing 
CC RE LE 
(mm) 
RMSE 
(ms) 
CC RE LE 
(mm) 
RMSE 
(ms) 
C1 BLW 0.75 0.36 7.9 13 0.79 0.38 7.6 8 
 Posterior MLW 0.79 0.28 5.3 7 0.81 0.22 4.2 5 
 LVA 0.80 0.37 7.6 9 0.83 0.39 8.2 10 
C2 Posterior MLW 0.70 0.29 8.2 11 0.71 0.32 7.8 14 
 MLW 0.73 0.26 6.9 10 0.72 0.25 6.7 8 
 LVA 0.69 0.21 5.1 9 0.72 0.24 5.7 6 
C3 MLW 0.65 0.31 7.4 11 0.67 0.32 6.4 12 
 LVA 0.62 0.25 9.1 8 0.68 0.36 8.8 7 
C4 BLW 0.70 0.24 10.2 8 0.77 0.18 9.1 6 
 Anterior MLW 0.78 0.32 8.1 7 0.86 0.31 8.3 7 
 MLW 0.68 0.24 6.3 12 0.69 0.20 5.2 9 
C5 BLW 0.72 0.25 6.5 8 0.74 0.26 6.1 7 
 MLW 0.78 0.23 5.7 7 0.79 0.27 5.3 6 
 LVA 0.68 0.33 7.3 11 0.69 0.34 7.2 12 
 Mean 0.72±0.06 0.28±0.05 7.3±1.4 9±2 0.75±0.06 0.29±0.07 6.9±1.5 8±3 
 
Note: CC, correlation coefficient; RE, relative error; LE, localization error; RMSE, 
root mean square error; BLW, basal left wall; MLW, middle left wall; LVA, left 
ventricle apex. (From Ref. (Han et al., 2012)) 
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of 8ms for the subepicardial-paced beat, and a CC of 0.71, an RE of 0.26, and an RMSE 
of 9ms for the subendocardial-paced beat. The origin of activation was localized to be 
6.6mm and 6.2mm for these two cases respectively.  
A total of 280 beats of single-site LV pacing from 14 subendocardial sites and 14 
subepicardial sites (10 beats for each single site) were analyzed. The performance of 
3DCEI in imaging ventricular activation during LV pacing is summarized in Table 7. A 
slightly better performance of imaging epicardial pacing was observed in terms of CC 
Table 8, Quantitative comparison between measured activation sequence and 
imaged activation sequence during single-site RV pacing in the canine heart.  
 
Canine Pacing Site CC RE LE (mm) RMSE (ms) 
C1 Anterior BRW 0.77 0.28 7.4 11 
 MRW 0.78 0.31 7.7 12 
 RVA 0.68 0.33 7.5 8 
C2 RVA 0.66 0.33 7.4 9 
 MRW 0.79 0.24 10.3 4 
 Anterior MRW 0.80 0.29 6.3 11 
 Posterior MRW 0.76 0.28 7.9 11 
 Anterior BRW 0.79 0.25 5.7 12 
C3 Posterior RVA 0.74 0.24 8.6 10 
 RVA 0.75 0.34 6.3 9 
 BRW 0.73 0.39 7.4 10 
 MRW 0.84 0.34 8.2 9 
C4 MRW 0.84 0.33 10.7 11 
 Posterior MRW 0.77 0.33 6.2 12 
 RVA 0.68 0.38 6.3 5 
C5 Posterior MRW 0.68 0.23 7.3 12 
 BRW 0.77 0.28 6.7 11 
 MRW 0.79 0.31 6.1 14 
 Mean 0.76±0.05 0.30±0.05 7.4±1.4 10±2 
 
Note: CC, correlation coefficient; RE, relative error; LE, localization error; RMSE, 
root mean square error; BRW, basal right wall; MRW, middle right wall; RVA, right 
ventricle apex. (From Ref. (Han et al., 2012)) 
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(0.75±0.06 versus 0.72±0.06, p<0.05, paired t-test) and LE (6.9±1.5mm versus 
7.3±1.4mm, p<0.05, paired t-test). The 3DCEI approach was able to identify the 
subendocardial origins for 10 subendocardial pacing sites, and subepicardial origins for 
12 subepicardial pacing sites (Han et al., 2012). Table 8 summarizes the performance of 
3DCEI in imaging ventricular activation during RV pacing (18 subepicardial pacing 
sites). For each animal, the imaging performance varied among difference anatomical 
pacing locations. In general, slightly decreased performance when imaging the global 
activation pattern during apical pacing in term of CC (0.76±0.05 versus 0.71±0.06, 
p<0.05, unpaired t-test) was observed averaging all animals. The averaged CC, RE, and 
RMSE over both LV and RV pacing were 0.74±0.06, 0.29±0.05, and 9±3ms respectively, 
suggesting good agreement between measured and estimated activation sequences. The 
averaged LE was 7.2±1.4mm, suggesting reasonable localization accuracy when imaging 
subjects with larger cardiac size. 
5.3.3. Ventricular Arrhythmias in the Canine Heart 
Frequent multiform PVCs and runs of nonsustained MVTs and PVTs were 
demonstrated during the infusion of NE (Han et al., 2012). A total of 96 ventricular 
ectopic beats including 26 PVCs, 5 couplets, 4 runs of MVTs and 6 runs of PVTs were 
analyzed. PVCs in each canine demonstrated different initial sites of activation. Twelve 
PVCs initiated in the LV and 14 in the RV. The PVC and VT beats were observed to 
initiate by a focal mechanism from a single site or sequentially from multiple sites in the 
subendocardium of ventricles, including lateral walls and apex. Quantitative comparisons 
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were made between non-invasively imaged activation sequence and invasively measured 
activation sequence for these PVCs and VTs beats in the canine heart. The comparison 
results are summarized in Table 9. The methods to image 96 PVC and VT beats are 
similar to those to image 460 beats paced from the LV or RV (p>0.05 for CC, RE, LE, 
and RMSE respectively, ANOVA test). 
 Fig.13 shows examples of two nonsustained MVT beats in canine C3. As shown in 
Fig.13.A for a representative MVT beat, this VT beat initiated at a subendocardial site at 
 
 
Fig. 13, Comparison between the 3D measured activation sequence and the 3D 
imaged activation sequence for two monomorphic ventricular tachycardia beats in 
the canine heart. (From Ref. (Han et al., 2012)) 
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anterior LV apex by a focal mechanism and propagated to the RV basal wall. The 
subsequent eight VT beats demonstrated focal initiation at the same LV site and similar 
global activation pattern. The averaged coupling interval of these maintained VT beats 
was 329±9ms. The imaged activation sequence matched measured activation sequence in 
its overall activation pattern, with a CC of 0.72, an RE of 0.28, and an RMSE of 8ms for 
this beat. The initiation of the activation was well localized with an LE of 7.2mm. The 
VT then accelerated into a fast four-beat episode, as shown in Fig.13.B. The activation 
pattern of these four beats looked similar and the initiation site of the activation moved to 
LV lateral wall. The averaged coupling interval for these four VT beats was 140±10ms. 
The imaged activation sequence was consistent with the direct measurement, with a CC 
of 0.78, an RE of 0.24, and an RMSE of 9ms. The initiation of the activation was well 
localized with an LE of 6.8mm for the fast VT beat shown in the red box of ECG in 
Fig.13.B.  
Another example is shown in Fig.14 for a four-beat PVT in canine C3. As shown in 
measured activation sequence in Fig.14.A, the first VT beat initiated at a RV site close to 
apex by a focal mechanism and propagated to the LV basal wall. The second beat 
initiated at anterior LV apex and activation pattern was similar to the beat shown in 
Fig.14.A. Beat 3 and beat 4 demonstrated the focal initiation at the same RV site close to 
posterior middle wall and similar global activation pattern, as shown in Fig.14.B. The 
coupling interval for this VT was 271±33ms. The imaged activation sequence matched 
the measured activation sequence in its overall activation pattern, with a CC of 0.73, an 
RE of 0.26, and an RMSE of 5ms for the beat in Fig.14.A, and a CC of 0.79, an RE of 
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0.25, and an RMSE of 10ms for the beat in Fig.14.B. The initiation of the activation was 
well localized with an LE of 7.4mm and 7.8mm respectively.  
 
5.4. Discussion 
In this chapter, we extended our validation of a physical-model-based 3DCEI 
technique in non-invasively reconstructing the 3D ventricular activation sequence and 
localizing the origin of activation in the canine heart with the aid of simultaneous 3D 
 
 
Fig. 14, Comparison between the 3D measured activation sequence and the 3D 
imaged activation sequence for two polymorphic ventricular tachycardia beats in 
the canine heart. (From Ref. (Han et al., 2012)) 
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intra-cardiac mapping from up to 216 intramural sites (Han et al., 2012). The quantitative 
comparison showed a good agreement between the non-invasively imaged activation 
sequence and its directly measured counterparts, as quantified by a CC of 0.74, an RE of 
0.29, and an RMSE of 9ms averaged over all paced and ectopic beats. The origins of the 
activation were reasonably estimated to be ~7mm from the initiation sites determined 
from intra-cardiac mapping. These findings imply that 3DCEI is feasible in 
reconstructing spatial pattern of 3D ventricular activation sequence and localizing the 
arrhythmogenic foci on a beat-to-beat basis (Han et al., 2012).  
The current imaging technique has a notable feature of imaging the cardiac activation 
Table 9, Quantitative comparison between measured activation sequence and 
imaged activation sequence in norepinephrine induced ventricular tachycardia in 
the canine heart.  
 
Canine Origin Site Arrhythmia Type No. of 
Ectopic beats 
CC RE LE 
(mm) 
RMSE 
(ms) 
C3 BRW PVT 1 0.67 0.30 8.7 10 
 MLW PVC, Couplet, MVT, PVT 18 0.71 0.26 5.8 9 
 Posterior MRW PVC, Couplet, PVT 11 0.78 0.23 7.5 9 
 LVA MVT, PVT 17 0.73 0.28 7.1 5 
C4 LVA MVT 16 0.72 0.33 10.6 10 
 MRW PVC 3 0.74 0.29 6.8 13 
 BRW PVC 1 0.64 0.35 8.0 14 
C5 MLW PVC, Couplet, MVT, PVT 16 0.73 0.23 7.6 7 
 BRW PVC, Couplet, PVT 9 0.68 0.33 10.8 12 
 LVA PVT 4 0.74 0.33 6.8 11 
Mean 0.72±0.03 0.28±0.04 7.9±1.8 10±3 
 
Note: CC, correlation coefficient; RE, relative error; LE, localization error; RMSE, 
root mean square error; BRW, basal right wall; MLW, middle left wall; MRW, 
middle right wall; LVA, left ventricle apex; RVA, right ventricle apex; PVC, 
premature ventricular complex; PVT, polymorphic ventricular tachycardia; MVT, 
monomorphic ventricular tachycardia. (From Ref. (Han et al., 2012)) 
 
    
70 
 
sequence throughout the 3D ventricular myocardium, which represents an important 
alternative to other heart surface based imaging techniques. It is also noted that this 
physical-model-based 3DCEI approach only uses the general biophysical relationships 
governing the cardiac electrical activity and does not need to build a sophisticated cardiac 
electrophysiological model (Han et al., 2012). By solving the spatial-temporal linear 
inverse problem, the 3DCEI approach estimated the instantaneous current density at each 
grid point and then estimate the local activation time as the time instant at peak of current 
density magnitude (Liu et al., 2006b) throughout the ventricular myocardium. It is 
challenging to estimate the “spatial” distribution of ECD distribution from BSPM at a 
given time point, but the activation time as determined from the peak of the ECD time 
course is not distorted substantially by such spatial relationship between ECD distribution 
and BSPM, as we have demonstrated in previous computer simulation (Han et al., 2008) 
and in animal experiments in rabbits (Han et al., 2011) and dogs (Han et al., 2012). 
Therefore, this physical-model-based 3DCEI approach is minimally dependent on the 
physiological knowledge of cardiac electrical properties and has the potential to image 
various cardiac arrhythmias. Note that our imaging approach involves solving a linear 
inverse problem and no initialization is needed (Liu et al., 2006b). 
Rigorous validation studies in biological systems are critical for any imaging 
approaches. The present study has used a novel in vivo experimental design in which 
BSPMs were obtained simultaneously with intramural electrical recordings from plunge-
needle electrodes in a closed-chest condition, and thus provided quantitative assessments 
of the 3DCEI approach. The present work extended our validation study of the canine 
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heart (Han et al., 2012). Compared with previous validation study in the rabbit heart (Han 
et al., 2011), the canine model provides larger heart-torso geometry and closer 
approximation to humans in cardiac size and electrophysiological characteristics. As we 
experienced in the rabbit heart, we also observed that there was a slight discrepancy in 
timing between the measured and computed activation times. This was due to the 
intrinsic smoothing effects when we solved the inverse problem, especially at the earliest 
and latest activation times, when body surface potentials are of relatively small 
magnitudes compared with noise (Han et al., 2012). As such, the resultant solution may 
lead to spatially smoothed images, and thus caused the slightly delayed initiation and 
premature termination. Nevertheless, the imaged activation sequence still provided a 
close match to the direct measurements, suggesting that important information regarding 
ventricular excitation (e.g., global activation pattern, regions of early and late activation) 
has been preserved in imaged results. Furthermore, the initiation sites were estimated to 
be ~7mm from the measured sites, suggesting that resolution in the canine heart (12-
times greater mass than rabbit heart) is associated with only a small (40%) change in 
resolution (versus ~5mm in rabbit heart) (Han et al., 2012). The present study suggests 
that the imaging accuracy does not necessarily scale linearly to the geometric size of the 
subject, but rather mainly determined by experimental procedures. It could be expected 
that in a clinical setting when human subjects are studied and different procedures 
involved (e.g., more BSPM electrodes would be used, and there would be no 
sternotomy), the imaging and localization errors would not increase further.  
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It is noted that two sets of UFCT images with and without IV contrast images were 
obtained on the anesthetized animals immediately after the mapping studies to accurately 
model the heart-torso geometry and localize the plunge-needle electrodes within the heart 
(Han et al., 2012). However, it was difficult to determine the exact name and label for 
each needle directly from the IV contrasted UFCT images for constructing the detailed 
heart model. Therefore, these needles were carefully replaced with labeled pins after the 
mapping study and the isolated heart was fixed in formalin. A third UFCT scan was 
performed on the formalin-fixed isolated heart to build the isolated heart model with 3D 
localization of plunge-needle electrodes, and the label for each needle in this isolated 
heart model was determined by photographs taken on the formalin-fixed isolated heart. 
This isolated heart model was carefully compared with the previously constructed 
detailed heart model from the heart-torso model so that the label of each needle within 
that detailed heart model could be identified. 
It has been shown from direct intra-cardiac mapping techniques (Pogwizd & Corr, 
1987; Pogwizd, 1994, 1995; Chung et al., 1997; Pogwizd et al., 1998; Zhang et al., 2000) 
that ventricular arrhythmias could arise from either subendocardium or subepicardium. 
Computational modeling of cardiac excitation plays an important role in dissecting the 
arrhythmia mechanisms throughout the 3D myocardium (Wei et al., 1995; Winslow et al., 
2000; Hunter et al., 2003; Kerckhoffs et al., 2006; Deo et al., 2010; Trayanova, 2011). 
The 3DCEI approach represents an important and novel means, which offers the 
potentials to provide the additional noninvasive assessments of the underlying arrhythmia 
mechanisms throughout the ventricular myocardium and may facilitate interventional 
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therapeutic procedures (e.g., catheter ablation) by using a more targeted approach and 
shortening the procedure time (Han et al., 2012).  
Single-beat noninvasive imaging of myocardial activation is important for the 
clinical diagnosis and management of hemodynamically unstable arrhythmias. 
Considering that not all arrhythmogenic substrates are accessible from endocardium, the 
necessity of applying epicardial ablation needs to be determined in some cases (Sosa et 
al., 2000). Being able to non-invasively assess the transmural location of the 
arrhythmogenic site prior to the procedure is likely to translate into a shortened time for 
the ablation procedure and potentially a reduction in risk to the patient by using a more 
targeted approach (Han et al., 2012). In the present study, we have infused NE in the 
canine heart to simulate the activation of the sympathetic nervous system and highly 
arrhythmic activities were induced including multiform PVCs and runs of nonsustained 
MVTs and PVTs. The measured activation sequence also showed that these arrhythmias 
usually originated within the subendocardium and may arise continuously from a single 
site or consecutively from multiple sites located at Purkinje cells or subendocardial 
myocardium (Han et al., 2012). The focal activation with NE induced VT resembles 
idiopathic VT in the human heart (Doppalapudi et al., 2009; Yamada et al., 2009). The 
origins have been well localized by the noninvasive 3DCEI approach with reasonably 
good accuracy. The performance is also consistent with those when imaging LV and RV 
pacing both in term of global pattern and timing difference. Furthermore, the beat-to-beat 
difference in activation pattern for the PVTs has been well characterized from the imaged 
activation maps. These results imply that this approach may be valuable for single-beat 
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imaging of focal ventricular arrhythmias arising in the deeper myocardium and 
facilitating the selection of clinical treatment options for these arrhythmias.  
It is noted that the current experimental protocol (e.g., median sternotomy) may 
affect the imaging accuracy due to the change of the torso volume conductor property. 
However, with careful surgery procedure (e.g., multilayer-suture chest closing) and CT 
images after the mapping study to accurately model the heart-torso geometry, we 
minimized such changes on the volume conductor (Han et al., 2012). Besides, in order to 
perform a quantitative comparison for the global pattern between the imaged and 
measured activation sequences, an interpolation algorithm was used in the intra-cardiac 
mapping procedure to obtain the measured activation sequence throughout the 3D 
ventricular myocardium. However, we found that this yielded only a very slight decrease 
in performance by comparing the CC and RE in one dog with and without interpolation 
(Han et al., 2012). 
In conclusion, the present study suggests that the 3DCEI approach can reconstruct 
3D ventricular activation sequence and localize the origin of activation during pacing and 
focal ventricular arrhythmias, as validated by 3D intra-cardiac mapping procedure in the 
canine heart. It also implies the potential application of 3DCEI as a clinically 
complimentary tool to aid in localizing the origins of ventricular arrhythmias and 
understanding the mechanism of these arrhythmias.  
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Chapter 6 
Experimental Investigation of Ventricular Arrhythmia 
Mechanisms 
 
6.1. Ventricular Arrhythmias during Drug-induced QT Prolongation in 
the Rabbit Heart 
6.1.1. Introduction 
Torsades de pointes (TdP) is a life-threatening arrhythmia that might degenerate into 
ventricular fibrillation and cause sudden cardiac death. TdP can occur during the 
prolongation of QT interval, as a consequence of a genetic alteration in ion channel 
behavior or because of the administration of certain drugs. Various investigations have 
been made to examine the potential of drugs to prolong QT interval and cause TdP, 
which usually exhibits a characteristic twisting of QRS complexes around the isoelectric 
axis (Dessertenne, 1966). TdP has a continuously changing QRS morphology and thus 
requires single-beat mapping techniques to characterize the dynamic activation pattern 
within the heart. Three-dimensional (3D) intra-cardiac mapping technique emerges as an 
important tool to investigate the electrophysiological mechanism underlying the 
ventricular arrhythmias associated with QT prolongation in in vivo animal models ( El-
Sherif et al., 1996; Murakawa et al., 1997; Schreiner et al., 2004; Boulaksil et al., 2011).  
Noninvasive cardiac electrical imaging techniques represent a novel means which 
offer the potential to help define the underlying arrhythmia mechanisms and may be used 
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to study the proarrhythmic effects of drug infusion and characterize the activation 
patterns of the associated arrhythmias. In this study, we investigate the 3D cardiac 
electrical imaging (3DCEI) technique to image TdP during drug-induced QT 
prolongation. The class III antiarrhythmic drug clofilium (Carlsson et al., 1992) and 
phenylephrine were infused in the in vivo rabbit model to prolong QT interval and induce 
ventricular arrhythmias (Batey & Coker, 2002) including premature ventricular 
complexes (PVCs), couplets, and TdPs. We performed simultaneous body surface 
potential mapping and 3D intra-cardiac mapping in a closed-chest condition in rabbits. 
The 3DCEI technique was applied to characterize the dynamic activation patterns of the 
induced arrhythmias. The imaged activation sequence was also compared with the 
simultaneously measured activation sequence from 3D intra-cardiac mapping. 
6.1.2. Study Design 
Eight healthy New Zealand white rabbits of either sex (3.6 to 4.3 kg) were studied 
under a protocol approved by the Institutional Animal Care and Use Committees of the 
University of Minnesota and the University of Alabama at Birmingham. The animal 
preparation and surgical procedure were as described in Chapter 4 (Han et al., 2011). 
Each rabbit was sedated with ketamine (35 mg/kg), intubated, and anesthetized using 2% 
isoflurane. Up to 64 repositionable BSPM electrodes were uniformly placed to cover the 
anterior-lateral chest up to the mid-axillary line. The heart was exposed via median 
sternotomy, and up to 27 transmural plunge-needle electrodes were inserted in the left 
ventricle (LV) and right ventricle (RV) of the rabbits. Each LV plunge-needle electrode 
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contains 8 bipolar electrode-pairs with an inter-electrode distance of 500 µm, while each 
RV electrode contains 2 bipolar electrode-pairs with an inter-electrode distance of 500 
µm. The chest and skin were then carefully closed with silk suture. Bipolar electrograms 
were continuously recorded from all electrode-pairs together with body surface potentials 
from surface electrodes. At the completion of the mapping study, ultra fast computed 
tomography (UFCT) scans were performed on the living rabbit to obtain the heart-torso 
anatomical information and extract the location of BSPM electrodes on the chest and 
plunge-needle electrodes within the myocardium (Han et al., 2011). When UFCT scans 
after mapping study were unavailable in three rabbits, the pre-operative UFCT images 
obtained before the open-chest surgery and mapping study were used for constructing the 
heart-torso geometrical model. The rabbit was then euthanized and the plunge-needle 
electrodes were carefully localized by replacing each with a labeled pin. The heart was 
fixed in formalin and underwent a UFCT scan to further facilitate precise 3D localization 
of the transmural electrodes. 
Ventricular arrhythmias including premature ventricular complexes (PVCs), 
couplets, and TdPs were induced by i.v. administration of clofilium and phenylephrine in 
combinations of various infusion rates and doses in the in vivo normal rabbit heart using 
an established protocol (Batey & Coker, 2002). Fig.15.A shows the protocol for drug 
infusion. For the first dose cycle, the phenylephrine infusion rate was begun at 75 nmol 
kg-1 min-1, and gradually increased to 150, 225 and 300 nmol kg-1 min-1 for every 3 min, 
while clofilium was infused at 20 nmol kg-1 min-1 5 min after the infusion of 
phenylephrine. This protocol was repeated at higher doses of clofilium at 60 and 200 
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nmol kg-1 min-1 with the same infusion rate for phenylephrine for the second and third 
dose cycle. There were 10 min intervals between different dose cycles (Batey & Coker, 
2002). 
Post-experiment data analysis was performed for the recorded ECG data. The QT 
interval was manually annotated from the beginning of Q wave to the end of the T wave. 
 
 
Fig. 15, (A) The drug infusion protocol for inducing torsade de pointes in the rabbit 
heart. (B) Example of an episode of torsades de pointes, where the twisting of the 
QRS complexes around the isoelectric line can be seen clearly. (C) The change of 
cycle length, QT interval, and rated-corrected QT (QTc) interval during the drug 
infusion for the three dose cycles.
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The rate-corrected QT (QTc) interval was calculated according to Carlsson’s formula: 
QTc = QT – 0.175(RR - 300) (Carlsson et al., 1992). 
Subject-specific realistic geometry heart-torso model was built from UFCT images 
and 3DCEI was applied to image the activation sequence for each rabbit. The imaged 
activation sequence was compared with the simultaneously direct measurements obtained 
from 3D intra-cardiac mapping. The measured activation sequence within the 3D 
ventricular myocardium was constructed in the method described in Chapter 4 when the 
heart and torso UFCT scans after mapping study were available (Han et al., 2011). In 
three rabbits, when heart and torso UFCT scans after mapping study were unavailable, an 
alternative isolated heart surface model was built from the post-operative UFCT images 
of the isolated heart with labeled pins (representing the sites of transmural needles), and 
this heart surface model has been carefully co-registered with the detailed heart model 
built from pre-operative UFCT images using anatomical landmarks (e.g., apex, outflow 
tract, and atria appendages). The orientation and location of each needle could then be 
projected to the detailed heart model. The 3D measured activation sequence could then be 
reconstructed throughout the ventricular myocardium. 
Numerical data are presented as mean ± SEM. The correlation coefficient (CC) was 
computed to quantify the agreement of overall activation pattern between the invasively 
measured activation sequence and the non-invasively imaged activation sequence. The 
localization error (LE) was computed to evaluate the performance of 3DCEI in localizing 
the origin of activation. Statistical significance of differences was evaluated by Student’s 
t-test, and a P value < 0.05 was considered statistically significant. 
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6.1.3. Results 
Eight healthy rabbits were studied in the present in vivo experiments. After insertion 
of plunge electrodes, closure of the chest did not alter heart rate or mean arterial blood 
pressure (232 ± 6 vs 238 ±6 bpm and 62±4 vs 62±3 mm Hg, respectively, P=NS vs pre-
closure) or total activation times of sinus beats (31±1ms vs 29±1ms, P=NS vs pre-
closure), which were consistent with previously published data in control rabbits in 
Chapter 4 and in (Pogwizd, 1995; Zhang et al., 2005; Han et al., 2011). The infusion of 
clofilium and phenylephrine led to the significant increase of the RR interval (255±14ms 
to 376±34ms, P<0.05), the QT interval (175±7ms to 274±31ms, P<0.05), and the QTc 
interval (183±5ms to 262±21ms, P<0.05) during the first dose cycle, as shown in 
Fig.15.C. The change of QT intervals was greater in the first dose cycle, as compared to 
the other two cycles. Table 10 summarizes the ventricular arrhythmias induced during the 
Table 10, Summary of data analysis for ventricular arrhythmias induced during the 
infusion of clofilium and phenylephrine in rabbit heart.  
 
Rabbit 
No. Sex PVC Couplet TdP 
Sites of Initiation 
RVOT LV 
1 F + + + Basal anterior. Basal anterior. 
2 F + + + Basal inferior, basal lateral.  Basal anterior, apical inferior. 
3 M + + + Basal lateral, basal anterior.  Basal anterior, middle inferior. 
4 F + + - Basal anterior.  Middle ante-lateral, apical inferior. 
5 F + + + Middle anterior, middle septum.  Apical lateral. 
6 F + + - Middle anterior. Middle ante-septal, apical anterior. 
7 F + + - Basal lateral. Basal ante-septal, basal anterior, basal 
infe-lateral. 
8 F + - - Basal lateral.  Apex. 
 
Note: PVC, premature ventricular complex; TdP, torsades de pointes; RVOT, right 
ventricle outflow tract; LV, left ventricle. 
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drug infusion. Ectopic activities in terms of multiform PVCs were observed in all animals 
during the infusion of clofilium and phenylephrine. TdPs were induced in four rabbits 
(See Figure 15.B for an example of TdP on ECG). One rabbit degenerated into 
ventricular fibrillation. Another two rabbits degenerated into asystole without ventricular 
fibrillation during the last dose cycle. 
The realistic geometry rabbit heart-torso model was constructed for each animal from 
the UFCT images. The rabbit ventricular myocardium was tessellated into 6987±330 
evenly-spaced grid points. The spatial resolution of the ventricle models was 1 mm. 
There were 151±7 intramural bipolar electrodes during 3D intra-cardiac mapping and 
59±1 BSPM electrodes on the rabbit body surface.  
 
 
Fig. 16, Comparison between the measured activation sequence and the imaged 
activation sequence for two premature ventricular contractions with different 
activation patterns in (A) and (B) during the infusion of phenylephrine and 
clofilium in rabbit. 
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Data analysis using 3DCEI and 3D intra-cardiac mapping performed on a total of 31 
isolated PVCs and 7 couplets from all rabbits suggests that these ectopic beats initiated in 
the subendocardium by focal activation. For each rabbits, the PVCs were observed to 
continuously initiate at several myocardial sites. The initiation sites covered both LV and 
RV outflow tract (RVOT). PVCs initiated with a coupling interval of 407±18ms and 
conducted with a total activation time of 53±2ms, while the coupling interval and total 
activation time for couplets were 387±32ms and 56±2ms respectively. Fig.16.A and 
Fig.16.B show the comparison between the measured and imaged activation sequences 
for two PVC beats in rabbit 1 during the first dose cycle. The first PVC initiated at basal 
anterior RVOT, and the wavefront then propagated over the septum and terminated at 
middle lateral LV. The second PVC initiated at the basal anterior LV and terminated at 
 
 
Fig. 17, Comparison between the measured activation sequence and the imaged 
activation sequence for a couplet with different activation patterns (A) and (B) during 
the infusion of phenylephrine and clofilium in rabbit. 
 
    
83 
 
posterior RV. The imaged results resembled the measured counterparts with respect to 
the overall activation patterns. Furthermore, the initiation sites were reconstructed at 
basal anterior RVOT and basal anterior LV respectively. Multiple PVCs and beats from 
TdPs in rabbit 1 were observed to be continuously firing at these two sites. Fig.17 shows 
an example of a couplet from rabbit 7. The first beat in Fig.17.A initiated at basal lateral 
wall of RVOT, and then the wavefront propagated over the septum and terminated at 
middle left wall. The second beat of this couplet initiated at the basal anterior septum of 
LV and terminated at RV lateral wall, as shown in Fig.17.B. The imaged results captured 
the overall activation patterns for this couplet and the initial sites were identified at basal 
lateral wall of RVOT and basal anterior septum of LV respectively. 
TdPs were induced in four rabbits. The QT interval and QTc interval of sinus beats 
right before the onset of first TdPs were increased as compared with those of sinus beats 
before drug infusion (285±29ms vs 180±14ms, P<0.05 for QT interval and 258±22ms vs 
188±9ms, P<0.05 for QTc interval). Data analysis was performed on a total of 73 beats 
from 10 episodes of TdPs (three to twenty-two beats for each episode). The averaged 
cycle length was 263±10ms and the activation time was 52±1ms. All these ectopic beats 
had focal initiation. Fig.18 shows an example of a ten-beat TdP in rabbit 2. The ECG 
morphology exhibited TdP form with twisted QRS complexes around the isoelectric axis 
in ECG lead I. More negative QRS-complexes turned into more positive complexes with 
an intervening transition zone. The averaged cycle length was 195±8ms and the total 
activation time was 52±5ms for this TdP. Fig.18.A and Fig.18.B demonstrate the 
activation patterns during beat 2 and 9 respectively. At the beginning of this TdP, 
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activation initiated from a subendocardial site of the basal LV. From there, it spread to 
the basal lateral wall of RVOT. This activation pattern did not change significantly for 
the first 6 ectopic beats and the site of latest activation during an ectopic beat was far 
from the site of earliest activation of the following beat. Beat 9 and beat 10 demonstrated 
another typical activation pattern, with initiation located at the RV base, as shown in 
Fig.18.B. The mapping results further suggested that in the middle of this TdP, there was 
simultaneous early activation at two sites, with one site located at basal lateral RVOT and 
another site located at basal LV, indicating the fusion beats with two completing foci. 
The imaged activation sequences clearly captured such dynamic transition of activation 
 
 
Fig. 18, Comparison between the measured activation sequence and the imaged 
activation sequence for ten-beat torsades de pointes during the infusion of 
phenylephrine and clofilium in rabbit.  
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patterns for this TdP. Besides, the two initiation sites of this TdP were well localized 
from the imaged activation maps. Fig.19 shows another example of a 6-beat TdP in rabbit 
3. In this TdP, three different activation patterns were observed as shown in Fig.19.A, 
Fig.19.B, and Fig.19.C. In Fig.19.A, the first ectopic beat had an initiation site at anterior 
RVOT, and then the initiation site shifted to anterior middle wall of LV for the second 
ectopic beat (Fig.19.B). The last four ectopic beats had continuously been firing at the 
same site at post-lateral wall of middle RV (Fig.19.C). The averaged cycle length was 
220±8ms and the activation time was 48±2ms for this TdP. The imaged activation 
sequence clearly captured such shift of initial activation sites and the overall activation 
patterns were in good agreement with the measurements. 
Averaging 111 ectopic beats from PVCs, couplets, and TdPs with single focal 
initiation site, the CC was 0.65±0.02, suggesting good agreement between the imaged 
 
 
Fig. 19, Comparison between the measured activation sequence and the imaged 
activation sequence for a six-beat torsades de pointes in rabbit 3. Panels (A), (B), 
and (C) show the activation sequence for the first three beats respectively.  
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activations sequence with the simultaneous measurements. Furthermore, the origin of 
arrhythmias was estimated to be 5.9±0.3 mm from the measured site, implying the 
reasonably good localization accuracy. 
6.1.4. Discussion 
The present study reports the use of a novel 3DCEI technique to non-invasively 
investigate the global activation pattern of cardiac arrhythmias during drug-induced QT-
prolongation in the in vivo rabbit heart. We showed that the infusion of clofilium and 
phenylephrine led to QT prolongation and induced different forms of ventricular 
arrhythmias during simultaneous body surface potential mapping and 3D intra-cardiac 
mapping. The data analysis suggested that the ectopic beats including PVCs, couplets, 
and TdPs were all initiated by a focal mechanism and the TdPs were initiated at focal 
sites and maintained with the dynamical shift of initiation sites or two completing foci. 
The non-invasively imaged activation sequences were in good correlation with the 
simultaneous intra-cardiac measurements with an averaged CC of 0.65±0.02 and LE of 
~5mm over 111 ectopic beats with single initiation site. These findings imply that 3DCEI 
is feasible in reconstructing global activation pattern and imaging dynamically changing 
arrhythmias on a beat-to-beat basis. 
This work extended our previous study in the control rabbits into investigating the 
3DCEI technique for imaging activation sequence in the setting of drug-induced 
prolongation of action potential and QT interval in rabbits. The imaging performance was 
consistent to our previous findings in the control rabbits in terms of CC and LE. The 
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close match between the imaged activation sequence and the direct measurement 
suggests that significant information regarding ventricular excitation (e.g., global 
activation pattern and regions with earliest and latest activation) has been preserved in the 
imaged activation maps in this animal model of human disease. 
The results suggest the potential clinical role of 3DCEI in diagnosing arrhythmia 
mechanisms and complementing cardiac mapping techniques. In this study, different 
ventricular arrhythmias including PVCs, couplets, and TdPs were induced during the 
infusion of clofilium and phenylephrine in the in vivo rabbit heart. We also observed 
short episodes of TdP that had a clear twisting of QRS complexes around the isoelectric 
line. The mechanism of TdP perpetuation is still not clear. Two possible mechanisms 
have been suggested: focal activity due to triggered activity and reentry. Both 
arrhythmogenic mechanisms have been documented during cardiac mapping studies ( El-
Sherif et al., 1996; Murakawa et al., 1997; Asano et al., 1997; Akar et al., 2002; Schreiner 
et al., 2004; Boulaksil et al., 2011). In the present study, both the 3D intra-cardiac 
mapping results and the noninvasive imaging results suggested the focal mechanism for 
these TdPs that were recorded during the study. The results further suggested the two 
competing foci which provided the underlying electrophysiological mechanism for the 
twisted QRS morphology in ECG for the episodes of TdP. While the current study cannot 
provide a clear cut answer to explain the discrepancies between focal and reentry 
mechanisms for TdP, the findings imply the potential role of 3DCEI for characterizing 
the activation patterns of dynamically-changing polymorphic ventricular arrhythmias and 
studying the proarrhythmic effects during drug infusion. 
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In conclusion, the present study suggests the capability of the 3DCEI technique to 
dynamically characterize the 3D ventricular activation patterns and localize the origin of 
activation during polymorphic ventricular arrhythmias with drug-induced QT 
prolongation, as evaluated by 3D intra-cardiac mapping procedure in the rabbit heart. The 
findings imply the potential application of 3DCEI to aid in studying the proarrhythmic 
effects of drug infusion and understanding the arrhythmia mechanisms associated with 
QT prolongation in the clinical setting. 
 
6.2. Ventricular Arrhythmias in a Canine Model of Nonischemic Heart 
Failure  
6.2.1. Introduction 
Congestive heart failure (HF) afflicts approximately 5 million individuals in the 
United States alone and is responsible for ~200,000 deaths per year, primarily from 
ventricular tachycardia (VT) degenerating to ventricular fibrillation (Packer, 1985). 
Noninvasive cardiac electric imaging techniques provide a much needed means which 
offers the potential to help with delineation of the underlying arrhythmia mechanisms 
related to HF and to facilitate corresponding selections of treatment options for HF and 
its related arrhythmias (e.g., guiding catheter ablation (Wood & Morady, 1999) or 
implantation of cardiac resynchronization therapy (Spragg et al., 2010)). In previous 
chapters, we have rigorously and extensively validated the 3DCEI technique in rabbit 
heart (Han et al., 2011) and canine heart (Han et al., 2012) without structure diseases. In 
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this study, we investigate the activation patterns of spontaneously occurring and induced 
VTs in a newly-developed arrhythmogenic canine model of nonischemic HF by using 
noninvasive 3DCEI and 3D intra-cardiac mapping in a close-chest condition.  
6.2.2. Study Design 
The experimental protocol, approved by the Institutional Animal Care and Use 
Committees of the University of Minnesota and the University of Alabama at 
Birmingham, was performed on two canines. HF in each dog was produced by induction 
of aortic insufficiency, which was later followed by constriction of the abdominal aorta. 
Aortic insufficiency was created via the carotid artery, in which a small catheter was 
pushed through the aortic valve between the LV and the aorta. Aortic constriction was 
created through an abdominal incision in which a suture was placed around the aorta 
and/or one renal artery to decrease the vessel diameter by ~50%. The dogs survived for 
up to a maximum of 24 months after which a terminal mapping study was performed. 
Progression of HF was assessed by LV end-diastolic dimension, LV end-systolic 
dimension and LV fractional shortening using Doppler echocardiography.  
Simultaneous body surface potential mapping and 3D intra-cardiac mapping was 
performed on the dogs when severe HF was developed for the terminal study. The animal 
preparation and surgical procedure were similar to the normal canine experiment in 
Chapter 5. There were 128 repositionable BSPM electrodes uniformly placed to cover 
both the anterior-lateral chest up to the mid-axillary line and the posterior chest. The 
heart was exposed via median sternotomy, and up to 47 transmural plunge-needle 
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electrodes were inserted in the LV and right ventricle (RV). Spontaneously occurring 
ventricular arrhythmias including PVC, couplet, and VT were recorded during the 
mapping study. Norepinephrine (NE) was later infused at 1.6-3.2μg/kg/min to further 
induce ventricular arrhythmias. At the completion of the mapping study, UFCT scans 
were performed on the living HF dog to obtain the needed anatomical information. The 
plunge-needle electrodes were then carefully localized by replacing each with a labeled 
pin (Han et al., 2012). A post-operative UFCT scan of the formalin-fixed isolated heart 
was subsequently performed to further facilitate precise 3D localization of the transmural 
electrodes.  
For each HF dog, the 3DCEI approach was applied to non-invasively reconstruct the 
activation sequence throughout the ventricular myocardium. The realistic geometry heart-
torso model was constructed from UFCT images. This heart-torso model was exported 
for further forward and inverse computation. The performance of 3DCEI was evaluated 
by comparing the non-invasively imaged activation sequence with the simultaneously 
direct measurements obtained from 3D intra-cardiac mapping. The measured activation 
sequence within the 3D ventricular myocardium was constructed as we did for control 
canine in Chapter 5. Data are expressed as mean ± SD. The CC was computed to quantify 
the agreement of overall activation pattern between the invasively measured activation 
sequence and the non-invasively imaged activation sequence. LE was calculated to 
evaluate the performance of 3DCEI in localizing the origin of activation. Statistical 
significance of differences was evaluated by Student’s t-test (paired or unpaired), and a P 
value < 0.05 was considered statistically significant. 
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6.2.3. Results  
With HF, LV end diastolic dimension increased by 39% (average of 3.72 cm to 5.18 
cm), and LV fraction shortening decreased by 14% (average of 44% to 37%). The 
realistic geometry canine heart-torso model was constructed from UFCT images obtained 
after the mapping study. The canine ventricular myocardium was tessellated into 
27853±5560 evenly-spaced grid points. The spatial resolution of the ventricle models was 
2 mm.  
Data analysis was performed on spontaneously occurring and NE-induced 
arrhythmias including 10 PVCs, 3 couplets, and 13 episodes of VTs. The NE-induced 
VTs (n=10) were longer than the spontaneously occurring VTs (n=3) (12±11 vs 4±1 
 
 
Fig. 20, Comparison between measured activation sequence and imaged activation 
sequence for a five-beat spontaneously occurring ventricular tachycardia in a heart 
failure canine.  
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beats long, p<0.05), and the NE-induced VTs were also more rapid than the 
spontaneously occurring VTs (cycle length of 240±46 vs 394±35 ms, p<0.05). Good 
correlation was obtained between imaged activation sequence and direct measurements 
(averaged CC of 0.70). Initiation sites were reconstructed to be ~10mm from measured 
sites, suggesting good localization in a large animal model with cardiac size similar to 
human. 
Fig.20 shows an example of a five-beat polymorphic VT spontaneously occurring 
without any drug intervention during the mapping study. The ECG shows that this VT 
was preceded by ventricular bigeminy, which was generated by the interaction between a 
sinus beat and a PVC beat. As shown in Fig.20.A, the first VT beat initiated at 
subendocardium of LV apex and the wavefront then terminated at the basal posterior 
ventricles. Both the 3DCEI-imaged results and direct invasive measurements showed that 
this VT beat had the same activation pattern with the PVCs in the preceding bigeminy. 
Fig.20.B shows the second VT beat, where the initiation site has shifted to the middle 
lateral wall of LV. This VT was maintained by shifting the initiation site within the two 
sites (in Fig.20.A and Fig.20.B) for the following three beats. The non-invasively imaged 
activation sequence showed good agreement with the measured activation sequence, and 
the shift of initiation site was well captured from the imaged maps. 
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Another example of a thirty one-beat polymorphic VT induced by NE is shown in 
Fig.21. All the ectopic beats in this VT had focal activation pattern. As shown in 
Fig.21.A, the beginning of this VT has been continuously firing at a high LV apex site 
slightly closer to anterior wall. However, starting from middle stage of this VT, other 
initiation sites were also observed among different ectopic beats. Fig.21.B shows that VT 
beat B (indicated in the red box of ECG lead II in the figure) had a slightly different 
activation pattern where the initiation site has shifted to the low LV apex. Fig.21.C shows 
another activation pattern for the VT beat C (also indicated in the red box of ECG lead II 
in the figure), where the initiation site moved to posterior base of LV. Such dynamic shift 
of initiation site has been well captured in the non-invasively imaged activation sequence. 
 
 
Fig. 21, Comparison between measured activation sequence and imaged activation 
sequence for a thirty one-beat ventricular tachycardia induced by norepinephrine in a 
heart failure canine.  
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6.2.4. Discussion  
In this study, we investigated the 3DCEI approach for characterizing the global 
activation pattern and localizing origin of activation during both the spontaneously 
occurring and NE-induced ventricular arrhythmias in a novel arrhythmogenic model of 
nonischemic HF. We showed that both the spontaneously occurring VTs and NE-induced 
VTs were initiated and maintained by a focal mechanism. Good agreement was obtained 
between the non-invasively imaged activation sequence and its directly measured 
counterpart, as quantified by a CC of ~0.70 and an LE of ~10mm averaged over 135 
ectopic beats. These findings imply that 3DCEI is feasible in non-invasively 
characterizing the spatial patterns of ventricular activation sequences, and localizing the 
arrhythmogenic foci on a beat-to-beat basis in the setting of nonischemic HF. 
This present work extended our previous study in the normal animals in evaluating 
the 3DCEI technique in the setting of diseased heart by using an arrhythmogenic canine 
model with nonischemic HF. The imaging performance was consistent to our previous 
findings in the control canines in terms of CC. The close match between the imaged 
activation sequence and the direct measurement suggests that significant information 
regarding ventricular excitation (e.g., global activation pattern and regions with earliest 
and latest activation) has been preserved in the imaged activation maps in such animal 
model with diseased heart. Considering the large increase of cardiac volume size, the 
slight increase of localization accuracy is reasonable, indicating the good localization of 
3DCEI in a large animal model with cardiac size similar to human. 
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Previous invasive 3D intra-cardiac mapping showed that spontaneously occurring 
PVCs and VTs in a nonischemic HF rabbit model were initiated in the subendocardium 
by a nonreentrant mechanism (Pogwizd, 1995). Focal mechanism was also observed in 
patients with idiopathic dilated cardiomyopathy (Pogwizd et al., 1998). In the present 
study, the findings for the mechanism of spontaneously occurring arrhythmias were 
consistent with the previous invasive mapping results. Similar to the spontaneously 
occurring VTs, the NE-induced VTs arose by a similar mechanism. However, the NE-
induced VTs were faster and longer than the spontaneously occurring VTs. The good 
correlation between the imaged activation sequence and the measured activation 
sequence implies that 3DCEI may become a noninvasive and important alternative to the 
direct intra-cardiac mapping. It could potentially improve clinical diagnosis and 
understanding of the arrhythmias mechanisms in patients and thus facilitate developing 
mechanism-based therapy and patient specific treatments. 
Another innovation of the present study is that we did not assume any a priori 
properties of the HF heart tissue. Rather, our model is based on the fundamental cardiac 
biophysics with regard to the myocardial excitation. With such basic assumption, our 
results demonstrate the feasibility of noninvasive activation imaging throughout the 3D 
myocardium in the HF canine, as validated from simultaneous intra-cardiac mapping. 
The present study suggests the potential application of 3DCEI as a clinically useful tool 
to aid diagnosis of ventricular arrhythmias associated with HF patients and to facilitate 
the selection of the corresponding mechanism-based treatment options for HF patients.  
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Chapter 7 
Conclusions and Future Work 
 
7.1. Conclusions 
Noninvasive imaging of the cardiac electrical activity is of great importance for both 
basic cardiovascular research and clinical medicine. In this dissertation, the recently 
developed physical-model-based three-dimensional cardiac electrical imaging (3DCEI) 
approach is rigorously investigated. 
The computer simulation provides a rigorous evaluation of the physical-model-based 
3DCEI under a realistic and well-controlled environment, and thus provides us the 
reference for understanding the experimental data. The present computer simulation 
study in a simulated rabbit model in single-site pacing and dual-site pacing demonstrates 
that the physical-model-based 3DCEI can localize the initial site of cardiac activation and 
image the cardiac activation sequences throughout the three-dimensional ventricular 
myocardium with reasonable accuracy. These promising results represent a significant 
step toward the potential clinical establishment of the 3DCEI approach and demonstrate 
the feasibility for experimentally validating this approach in animals. 
The performance of 3DCEI is experimentally and rigorously evaluated through well-
controlled animal validation studies in both the small animal model (thirteen rabbits) and 
large animal model (five canines). By comparing the 3DCEI-imaged results with 
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simultaneous measurements through intra-cardiac mapping with plunge-needle electrodes 
inserted throughout the myocardium, the experimental investigations validate the ability 
of 3DCEI to image cardiac activation sequence and localize the origin of activation 
during single-site and dual-site paced rhythms, as well as norepinephrine-induced 
ventricular arrhythmnias. The consistent agreement between the non-invasively imaged 
activation sequence and its directly measured counterparts in both the rabbit heart and 
canine heart, implies that 3DCEI is feasible in reconstructing the spatial patterns of 
ventricular activation sequences, localizing the focal or multiple arrhythmogenic foci, and 
imaging dynamically changing arrhythmia on a beat-to-beat basis. It also implies the 
potential application of 3DCEI as a clinically useful tool to aid in localizing the origins of 
ventricular arrhythmias and understanding the mechanism of these arrhythmias. 
The clinical relevance and the potential clinical role of 3DCEI are further 
demonstrated by investigating 3DCEI in the animal models simulating cardiovascular 
diseases in human. In one group, the QT prolongation is induced in eight rabbits using a 
novel protocol of drug infusion and 3DCEI is used to characterize the activation pattern 
for the ventricular arrhythmias accociated with QT prolongation. The promising results 
imply the potential application of 3DCEI to aid in studying the proarrhythmic effects of 
drug infusion and understanding the arrhythmia mechanisms associated with QT 
prolongation in the clinical setting. In another group, 3DCEI is used to investigate the 
activation patterns of spontaneously occurring and induced ventricular tachycardia in a 
newly-developed arrhythmogenic canine model of nonischemic heart failure in two 
canines. The promising results suggest the potential application of 3DCEI as a clinically 
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useful tool to aid diagnosis of ventricular arrhythmias associated with heart failure 
patients.  
In summary, the present dissertation study investigates a novel physical-model-based 
3DCEI approach through both computer simulation and animal experiments with 
difference electrophysiological conditions. The promising results presented in this 
dissertation study suggest that this cardiac electrical imaging approach may provide an 
important alternative for non-invasively imaging cardiac electrical activity throughout 
ventricular myocardium and may potentially become an important tool to facilitate 
clinical diagnosis and treatments of malignant ventricular arrhythmias.   
 
7.2. Future Work  
The present dissertation study provides promising results on the physical-model-
based 3DCEI approach. On the other hand, there are some works that can be made for the 
further improvement of 3DCEI. 
In the present dissertation study, we focus on investigating 3DCEI in imaging 
ventricular electrical activity during both the computer simulation study and animal 
experiments, without investigating the electrical activity in both atria. It is noted that 
cardiac electrical activities are distributed throughout the whole heart, and there are 
interactions between atria and ventricles. Besides, atrial arrhythmias account for a very 
large patient population. Therefore in the future study, it would be important to extend 
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the development of 3DCEI methodology in atrial arrhythmias, such as atrial tachycardia, 
atrial flutter, and atrial fibrillation.   
The significance of this dissertation study lies in that the 3DCEI technique would 
facilitate clinical diagnosis and management of various cardiac arrhythmias. While in this 
dissertation study we demonstrate that 3DCEI is capable of imaging experimentally-
induced ventricular arrhythmias, the present dissertation study is limited in animal 
experiments. Besides, some human arrhythmias can be much more complex than those 
we have induced and investigated in animals. Under certain conditions, the arrhythmias 
in human may be very different from those in animal models. Therefore, to further 
develop and improve the 3DCEI approach, it would be very important to validate the 
approach in human subjects, to quantify its capability of imaging human arrhythmias, and 
to establish its clinical role in facilitating clinical treatment of those cardiac diseases. 
The fundamental basis of the 3DCEI lies in mathematically modeling the cardiac 
electrical activity using equivalent cardiac source models and extracting the cardiac 
excitation information from the inverse solution of the equivalent source model. In this 
dissertation project, we mainly focus on extracting cardiac activation sequence from the 
reconstructed equivalent current densities. On the other hand, other clinically important 
information can also be extracted from the equivalent source models. For example, the 
myocardial infarction substrate may be identified directly from equivalent current 
densities. Therefore, in the future study, it would be important to extend the 3DCEI in 
extracting other clinically useful features (e.g., localization of myocardium infarction) 
from the inverse solution of equivalent source models. 
    
100 
 
In the present dissertation study, we report the localization accuracy of the 3DCEI 
technique to be between 5-10 mm for localizing origin of activation, varying among the 
size of the heart.  Such localization accuracy is reasonable and promising, since it is also 
consistent with the outcome of cardiac catheter ablation (ablation usually creates a lesion 
of 5-10mm (Simmons et al., 1996)) and thus the results have clinical values in facilitating 
management of cardiac arrhythmias. However, there is also room for further development 
of the method and improving accuracy of the imaging algorithms by applying additional 
physical constraints or physiologically meaningful constraints. 
In conclusion, despite many challenges, with the integrated efforts of methodology 
development, experimental investigation, and clinical validation, it can be foreseen that 
the physical-model-based 3DCEI approach will become an important clinical tool for 
noninvasive diagnosis of cardiac abnormalities, and may also improve our understanding 
of the basic physiological mechanisms underlying the cardiac electrical activity. 
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